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Introduction: Lipid signaling refers to events involving lipid messengers that bind proteins, 
which in turn mediate the effects of these lipids on specific cellular responses. The identification 
of lipid messengers and mechanisms of their interactions with the target proteins are the main 
pillars of understanding lipid signaling. Lipids function as signals in two ways: (i) chemical 
modifications of lipids, and (ii) asymmetric distribution of lipids.  
Methodology: We utilized computational approaches, including molecular docking, molecular 
dynamics simulations and bioinformatics, to explore the mechanism of lipid signaling in several 
cellular pathways.  
Oxygenated (ox-)lipid signaling in anti-cancer immunity: Oxygenation is the major metabolic 
modification generating numerous new molecular species of lipids, which can be involved in 
signaling processes. The structural role of ox-lipids in lipid droplets (LDs) present in tumor 
environments was examined. The presence of polar oxygenated functional group(s) in 
oxygenated lipids (ox-lipids) resulted in to their localization in the LD surface. We then explored 
possible interactions of ox-lipids with the heat shock protein 70 (HSP70), one of the key-proteins 
in antigen-cross presentation. Our data revealed that HSP70 specifically recognizes the neutral 
ox-lipids on the LD surface leading to tight binding and deep penetration into the phospholipid 
monolayer of the LD.  
 v 
Lipoxygenase-driven phospholipid peroxidation signaling: we explored the catalytic and 
inhibition mechanisms of lipoxygenases (LOX’s), the main generators of ox-lipids in ferroptosis 
cell death. We revealed the mechanism of peroxidation of esterified fatty acid via LOX’s and 
provided a possible mechanism of inhibition of LOX’s, particularly by vitamin E’s. 
Lipid signaling due to asymmetric distribution of cardiolipin: The mitochondrial signature 
phospholipid, cardiolipin (CL), is asymmetrically distributed in the inner mitochondrial 
membrane. CL asymmetry is disrupted through a process called “CL externalization”, which can 
be recognized by many proteins. We described the molecular details of cardiolipin interactions 
with cytochrome c and LC3, the key players of apoptosis and mitophagy pathways, respectively. 
The CL-binding site(s) on these proteins were identified. Our data suggested that the strong 
interactions of cyt-c/LC3 with CL-containing membranes lead to CL clustering. This clustering 
in turn induces a negative curvature on the membrane surface. 
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1.0 CHAPTER 1: INTRODUCTION 
1.1 BACKGROUND 
1.1.1 Lipidome and Lipid Diversity 
According to the International Lipid Classification and Nomenclature Committee, lipids are 
described as “hydrophobic or amphipathic small molecules that may originate entirely or in part 
by carbanion-based condensations of thioesters (fatty acyls, glycerolipids, glycerophospholipids, 
sphingolipids, saccharolipids, and polyketides) and/or by carbocation-based condensations of 
isoprene units (prenol lipids and sterol lipids) [1].” These eight lipid classes are further 
subdivided based on chemical structures. Although structurally lipids are apparently composed 
of limited number of ‘building blocks’, they potentially can generate 9,000–100,000 various 
molecular species [2]. The totality of lipids in cells is referred as the lipidome [3]. 
 
Figure 1-1 Relative distribution of lipids comparing 
other biological building blocks in human plasma.  
Amino acids and nucleic acids are demonstrated 
without consideration of their contribution in proteins 
and DNA/RNA. The relative distribution is based on 
weight (grams per deciliter) (adapted from [3]). 
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Lipids are one of the four major molecular components of the metabolome, along with 
nucleotides, sugars and amino acids (Figure 1-1). Lipids represent more than 60% in the relative 
weight distribution of the metabolome’s components. The word “lipidome” has been coined in 
the context of omics in modern biology, within the area of lipidomics [4]. 
1.1.2 Lipid Signaling 
Lipids have many key roles enabling them to function as energy storage compartments, structural 
moieties and signaling molecules [4]. Although the role of lipids in energy storage systems and 
structural organization have been widely explored for a long time, the role of lipids in cellular 
signaling pathways still is an open area to study. Lipid signaling refers to events involving lipid 
messengers that bind proteins/enzymes, which in turn mediate the effects of these lipids on 
specific cellular responses [5]. Accordingly, the identification of lipid messengers and the 
mechanisms of their interactions with target proteins are the key focal points in understanding 
the lipid signaling. In general, there are two ways that lipids function as signals: (i) via collapse 
of asymmetric distribution, and (ii) via chemical modification [6].  
1.1.2.1 Asymmetric distributions of lipids  
Lipid asymmetry is a general property of biological membranes. The type of asymmetry can vary 
from one membrane to another [7]. The maintenance of this asymmetry and its disturbances are 
used for signaling purposes. For example, in the plasma membrane, phosphatidylserine (PS) is 
exclusively located at the cytoplasmic side. However, the externalization of PS on the plasma 
  3 
membrane of the apoptotic cell acts as a recognition signal for macrophages [8]. The 
asymmetrical distributions are typically pronounced in cases of cardiolipin (CL)-containing 
membranes as well. The mitochondrial signature phospholipid (PL), CL, possesses four acyl 
chains instead of two and is a universal component of mitochondria in all eukaryotes [9, 10]. In 
addition to trans-membrane asymmetry, CLs also display molecular asymmetry. The latter is due 
to the chirality of the CL molecule. Even apparently structurally symmetrical CL species with 
identical fatty acid residues such as tetra-linoleoyl-CL or tetra-oleoyl-CL have two chemically 
distinct phosphatidyl moieties, i.e., two chiral centers in the pro-R and pro-S positions relative to 
the central carbon of the glycerol bridge. The potential role of this difference in the ionization 
states of CLs in the microenvironment facing the mitochondrial matrix, which exhibits a basic 
pH, may be quite significant [11]. It is tempting to speculate that this propensity of CLs may be 
responsive to changes in intra-mitochondrial pH/membrane potential which affect CL 
distribution and trans-membrane asymmetry. For CL species with non-identical acyls, the 
molecular asymmetry may lead to even more “dramatic” consequences resulting not only in 
structural “fitness” to accommodate the optimal conformations of the CLs bound to proteins but 
also in altered metabolic fate realized via (per)oxidation and hydrolysis reactions and 
accumulation of oxidatively modified CL species and lyso-CLs [10].  
In bacteria and in eukaryotes, the cellular distribution of CLs is asymmetric. Normally, 
CLs are found predominantly in the inner membranes of bacterial cells [12, 13]. It is known that 
accumulation of CL at the poles of bacteria induce negative curvature, which is analogous to the 
curved region of cristae in the inner mitochondrial membrane (IMM). Coarse-grained molecular 
dynamics simulations proved that asymmetric distribution of CL between leaflets of a bilayer 
induces negative curvature on the CL enriched-side (Figure 1-2). 
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Figure 1-2 Asymmetric distribution of 
CL between two leaflets induces 
membrane curvature, characteristic of 
the IMM and bacterial poles. 
The final configuration (at t=500 ns) of 
CGMD simulations from the symmetric 
distribution of DOPC in the membrane 
(left) does not display significant 
curvature, while the asymmetric insertion 
of CL (right) leads to a substantial 
negative curvature toward the CL 
enriched side. Representation guide: pink, 
choline and phosphate groups of DOPC; 
cyan, acyl chains of CL and DOPC; blue, 
glycerol moiety of DOPC and CL; red, 
phosphate groups of CL; DOPCs have been represented as transparent in the asymmetric membrane; water and ions 
have been removed for clarity. CGMD, coarse-grained molecular dynamics simulations; DOPC, 1,2-dioleoyl-sn-
glycero-3-ethylphosphocholine; IMM, inner mitochondrial membrane [14]. 
 
In eukaryotes, this asymmetry is even more robust: CLs are mitochondria-specific and, in 
functional mitochondria maintaining a “healthy” membrane potential, CLs are confined almost 
exclusively to the inner mitochondrial membrane (IMM) with a higher abundance in the matrix 
leaflet [15]. Indeed, recent studies have revealed that both in bacteria and in mitochondria, the 
collapse of CL asymmetry represents a signaling event. The exact meaning of this signaling and 
its significance for bacteria/host interactions have not yet been fully deciphered [16-18] although 
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biochemical mechanisms involved in CL translocation have been partially identified [19, 20]. It 
has been demonstrated that gram-negative bacteria externalize their CLs on the membrane 
surface as they encounter host cells [20].  
This asymmetry has been used as an important recognition mechanism to distinguish the 
healthy mitochondria —capable of maintaining the CL trans-membrane gradient— from injured 
organelles where this asymmetry is collapsing. This results in CL externalization on the surface 
of mitochondria, recognition of CLs by components of the autophageal system (LC3) and 
elimination of the damaged mitochondria, analogous to the recognition of externalized 
phosphatidylserine on the cell surface for elimination by professional phagocytes (Figure 1-3). 
Diversification of CLs in eukaryotic cells yielded multiplicity of its polyunsaturated species 
whose oxidation may serve additional signaling purposes. Indeed, peroxidation of CLs and 
accumulation of oxCLs is essential for the completion of the cell death program, thus offering 
new opportunities for drug discovery. Our understanding of mitochondrial functions – in 
addition to being a powerhouse of cells – is currently extended to a concept of their role as a 
major regulatory platform involved in numerous intra- and extracellular functions, from 
coordination of metabolism and cell death to immune responses in which CLs/oxCLs are 
considered as important signaling molecules. There is an intuitive perception that the remarkably 
diversified CLs/oxCLs species in eukaryotes relative to prokaryotes may represent a unique 
mitochondrial communication language. The biochemical and signaling principles of this 
language, its vocabulary and meaning of its words are yet to be deciphered. 
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Figure 1-3 Mitophagic translocation of cardiolipin: cardiolipin (CL) is synthesized by cardiolipin synthase 
(CLS) in the inner leaflet to of the IMM. 
Externalization of cardiolipin to the mitochondrial surface through a mechanism involving phospholipid scramblase-
3 (PLS3) is a prerequisite for its recognition by LC3 as a mitophagic “eat-me signal” that targets dysfunctional 
mitochondria to the autophagosomal machinery. Nucleoside diphosphate kinase (NDPK-D) may physically facilitate 
CL trans-membrane transfer. NDPK-D regulates the balance between di- and tri-phospho-nucleotides, providing 
GTP for the GTPase activity of OPA1. By forming a hexamer in the intermembrane space, NDPK-D can physically 
bridge the IMM and OMM. The switch from a phosphotransfer to a cardiolipin-translocator would thus facilitate the 
redistribution of cardiolipins between the IMM and the OMM (adapted from [21]). 
1.1.2.2 Lipid modifications 
In addition to an already broad spectrum of different lipids, further diversification is achieved 
through chemical modification, mainly oxygenation, of free/esterified poly-unsaturated fatty 
acids (PUFA’s) [10]. Correspondingly, both free and esterified oxygenated lipid (ox-lipid) 
species can be involved in the signal transduction processes by interacting with target 
proteins/enzymes. The presence of one or more very polar oxygenated groups in the structure of 
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ox-lipids induces a significant change in the LogP (the partition coefficient). Hence, ox-lipids 
can change the lipid partitioning, and consequently the structure of lipid-containing 
compartments such as lipid membranes and lipid droplets (LDs). 
In a lipid bilayer, it has been documented that the truncated oxidized sn-2 fatty acid 
moiety protrudes into the aqueous phase, rendering it accessible for recognition by various 
proteins, e.g CD36 [22]. The addition of a polar oxygenated group on numerous peroxidized 
fatty acids reorients the acyl chain, whereby it flips out of the membrane and protrudes into the 
aqueous compartment, which is called the “lipid Whisker model” (Figure 1-4) [22]. Additionally, 
lipid oxidation can affect the membrane fluidity. It has been shown that a highly oxidized 
membrane is susceptible to losing its integrity [22]. 
While presence of ox-lipids in LDL and HDL has been reported, the structural and 
functional roles of ox-lipids in LD have never been studied. We have recently documented that 
oxidatively modified triacylglycerols (ox-TAGs) of LDs alters their partitioning whereby 
oxidized lipids migrate into the outer monolayer of the LD. We proposed that the ox-lipids 
located on the LD surface may be involved in anti-tumor immune suppression [23, 24]. 
Additionally, we suggested that these ox-lipids can be recognized by heat shock protein 70 
(HSP70) —a key player in exogenous antigen processing.  
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Figure 1-4 Predicted conformational models of oxidized choline glycerophospholipid inside the membranes, 
containing DMPC or DPPC/cholesterol.  
Representation guide: Light blue: hydrogen; black: carbon; dark blue: nitrogen; red: oxygen; purple: phosphorus 
(adapted from [22]). 
1.2 OPEN QUESTIONS, GOALS AND ACCOMPLISHMENTS 
1.2.1 Open Questions and Goals 
Compelling evidence suggests that lipid signaling events are involved in many cellular pathways, 
demanding answers to the important questions: Which types of lipid species play an active role 
in lipid signaling and what are these roles? How does the asymmetric distribution of lipids affect 
the structures of membranes? How does lipid oxygenation change the LD structure? What is the 
mechanism of interaction of proteins/enzymes with LDs and membranes containing lipid 
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signals? To address these biophysical questions in molecular detail for several cellular pathways 
— antigen-cross presentation, ferroptosis, apoptosis and mitophagy— we applied a combination 
of molecular dynamics (MD) simulations, molecular docking, and bioinformatics tools. 
1.2.2 Significance of the Study 
Maintaining or perturbing lipid asymmetry, and/or chemical modifications of lipids can trigger 
signaling events. The application of computational approaches provides capable tools to perform 
such mechanistic studies.  
Chemical modifications of lipids, mainly peroxidation, generate an array of lipid signals. 
These ox-lipids may contain a chemically reactive compound such as aldehyde. A myriad of 
oxygenated products can be made through three lipid peroxidation mechanisms, (i) autoxidation 
by free radical reaction, (ii) photo-oxidation and (iii) enzyme action. The ox-lipids generated 
though any of the aforementioned pathways mostly convey lethal signals. It has been recently 
described that the presence of ox-lipids act as signals in cancer and the ferroptosis cell death 
pathways [25, 26]. For the former case, it has been established that LDs containing ox-lipids in a 
tumor environment suppress antigen cross-presentation (ACP), essential for anti-tumor 
immunity. In the latter case, we concentrated primarily on shedding light on the mechanism of 
lipid peroxidation via a large family of enzymes called, “lipoxygenases”. The lack of knowledge 
and proper tools to screen the lipid peroxidation products to determine those involved in 
signaling processes leave it an open and highly active research area.  
In the first two chapters, we predominantly explored the mechanism of action of recently 
discovered lipid mediators involved in antigen-cross presentation and ferroptosis pathways. 
Since the MD simulations provide the thermodynamically favored state of the system (the local 
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or global minima in free energy landscape), this method is capable of predicting structural 
changes due to the presence of ox-lipids in membranes and LDs. Additionally, it is a proper tool 
to perform biophysical studies to understand the preferred binding sites, binding modes, and 
consequences these interactions on the involved proteins and lipid-containing organizations. We 
clearly demonstrated that the target proteins recognize these structural changes, which can be 
explored using computational methods. 
Several machineries contribute to maintaining cardiolipin’s asymmetry necessary in 
providing the desired membrane potential for healthy mitochondria [27], and inducing the 
membrane curvature that is involved in cristae formation. However, during apoptosis and 
mitophagy the collapse of asymmetry mediates the signal of “CL externalization”. To this end, 
CL is translocated from the inner leaflet of IMM to the outer leaflet of OMM [26]. The 
externalized CL is initially recognized by cytochrome c (cyt-c), a key player of apoptosis and 
located in the IMS. Once CL migrates to the mitochondrial surface due to an injury, it can be 
recognized by microtubule-associated protein 1 light chain 3 (LC3), an essential protein of the 
autophagic machinery mainly localized on autophagosomes [28]. Due to lack of comprehensive 
mechanistic studies to discover the molecular details of CL-containing membrane interactions 
with known target proteins, we carefully examined the interactions of the emulated 
mitochondrial membranes, including the IMM and the OMM, with cyt-c and LC3 to determine 
how CL externalization triggers apoptosis and mitophagy. 
Although the outcome of computational approaches needs to be validated 
directly/indirectly by experimental approaches, computer modeling likely provides trustworthy 
insights into the dominant mechanisms that are not accessible to experimentalists. Additionally, 
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the computational approaches are mainly inexpensive, fast and offer flexible methods to perform 
such mechanistic studies.  
1.2.3 Summary of Thesis Contributions 
Lipids function as signals in two ways: (i) chemical modifications of lipids, and (ii) asymmetric 
distribution of lipids. To understand the mechanism of action of lipid signals in the former, we 
conducted two studies, (i) ox-lipid signaling in cancer (chapter 3), and (ii) lipoxygenase-
dependent lipid signaling in the ferroptosis cell death pathway (chapter 4). To investigate the 
mechanism of CL signaling in the latter, we performed two studies, (i) CL-signaling in apoptosis 
through interactions of CL/cyt-c, and (ii) CL-signaling in mitophagy through interactions of 
CL/LC3 (both in chapter 5). 
The ox-lipid signaling in cancer (chapter 3): LDs —ubiquitous organelles in all cells— are 
comprised of two lipid phases, a neutral lipids core covered by a phospholipid monolayer. The 
hydrophobic core is mainly composed of triacylglycerols (TAGs). Notably, oxidizable PUFA-
TAGs constitute a significant fraction of the total amount of neutral lipids in LDs. In the tumor 
microenvironment, LC-MS data proved the presence of a large amount of ox-lipids in LDs. 
While their origin and mechanisms of formation remain to be elucidated, the appearance of 
TAGs with these polar oxygenated groups in the hydrophobic core on LDs may act as an 
important factor shifting the equilibrium properties of the LD where the perturbed balance 
between hydrophobic and hydrophilic groups results in altered distributions of the constituent 
lipids. Indeed, our computational modeling of LDs containing oxidized neutral lipids indicated 
that the presence of oxTAGs inside the hydrophobic LD was thermodynamically unstable, 
resulting in their migration toward the hydrophilic surface. The ox-TAGs disturbed the stability 
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of the two distinctive LD phases, and their presence causes partitioning of oxTAGs into the 
phospholipid monolayer. The accumulation and presence of oxidized neutral lipids in the LD 
monolayer suggests their potential roles in lipid mediator signaling networks. In spite of the fact 
that this study presents a simplified model of oxidized lipid dynamics in LDs, our data suggest 
novel mechanisms of biochemical processing of TAGs and oxTAGs that raise challenging 
biophysical questions.  
Next, we explored the possible target proteins to mediate the role of ox-lipids on the LD 
surface in antigen cross presentation (ACP). Among the many proteins involved in ACP, heat 
shock proteins —HSP70 and HSP90— play roles in translocation of exogenous antigens, either 
from the ER-endosome to the cytosol or from the cytosol to the proteasome. According to recent 
data that described the localization of HSP70 on the LD surface in a tumor environment, we 
explored the interactions of HSP70 with oxLD and LD. We demonstrated that ox-lipids on the 
LD surface are recognized by HSP70. Among three candidate oxTAGs-binding sites of HSP70, 
the site containing a beta-hairpin domain deeply penetrated into the phospholipid monolayer. We 
additionally proposed that these interactions might be irreversible due to possible covalent 
binding between aldehyde groups of ox-lipids and lysine residues present in the ox-lipid-biding 
site of HSP70. The anchoring of HSP70 on the oxLD surface alters HSP70 from its original 
function in ACP. In conclusion, using computational approaches, we suggest a novel mechanism 
of ACP suppression through interactions of HSP70 and oxLDs. Therefore, we propose a 
biological role and resulting pathological significance of oxidized neutral lipid accumulation at 
the LD surface monolayer. 
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The lipoxygenase-dependent lipid signaling in ferroptosis (chapter 4): Ferroptosis is a newly 
coined term for one of the programmed death pathways that emphasizes the mechanism of cell 
demise associated with the dysregulation of thiol and lipid oxidative metabolism controlled by 
GPX4. It has been shown that the accumulation of PE-OOH is confined to the extra-
mitochondrial ER-associated compartments where several iron proteins —COX, LOX and 
CYP450— can generate PUFA hydroperoxy-intermediates as the primary molecular products of 
their reactions. Of those, only LOX’s —non-heme-iron enzymes— are the prime candidate-
catalysts and sources of the ferroptotic oxygenated PE-species. In this study, we aimed 
specifically to understand the mechanism of LOX-driven lipid signaling.  
Molecular modeling showed that three types of free PUFA, including AA, AdaA and 
DHA bound similarly to the catalytic site of 15LOX-2 with almost equivalent binding energies 
(~ -7.0 kcal/mol). The availability and the accessibility of the substrate can affect the enzyme 
kinetics, which cannot be addressed using molecular modeling. Next, for the first time, we 
explored the probability of the oxygenation of PLs via 5, 12 and 15LOX, using computational 
methods. Our data proposed —five out of six— classes of SA-based PLs can effectively interact 
with the active site of LOXs. Only SA-PS demonstrated significantly low affinities toward all 
three LOX’s. Following the experimental data, we tested two main lipid biomarkers of 
ferroptosis, SA-PE and SAdrA-PE. The analogous binding pose and binding affinities predicted 
that both species are equally susceptible to be a substrate of 15LOX-2. Yet, the selectivity of 
LOX towards PE species was not confirmed using our modeling data. In the case of esterified 
substrates, a question remains to be answered —how would LOX identify PUFA-PE species, 
among many other phospholipids with AA- and AdrA-residues for the selective peroxidation? 
The mechanism based on the formation of specific PE-LOX complexes is not compatible with 
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our computer modeling data indicating that diversified (phospho)lipid classes can effectively 
interact with LOX. The computer modeling indicates that PC displays a poor capacity for 
binding 15LOX as compared to PE.  
To decipher the membrane binding mechanism of 15LOX-2, we ran long CGMD 
simulations and proved it bound with similar orientation for N-terminal membrane binding 
(NMB) domain, but quite different for the helical active site. These results can be ascribed to the 
presence of a coil-like structure functioning as a hinge and provide flexibility for the active site. 
This flexibility can change the accessibility of the active site opening to the substrate. This can 
affect the activation mechanism of LOXs, but needs further evaluations. Additionally, we found 
that a long loop in NMB domain with the highest degree of hydrophobicity is responsible for 
membrane binding —in line with previous studies [29]. 
The inhibition mechanisms of LOXs, particularly 15LOX, were examined using a known 
inhibitor, bacalein (as a positive control), and tested/specific inhibitors of ferroptotic cell death. 
In addition to the aforementioned group of the small molecules, vitamin Es —eight isoforms— 
also were inspected to possibly explain their mechanism of action on LOX —and indirectly on 
ferroptosis. Interestingly, all the tested compounds in this study bound to the active site of LOXs. 
The specific ferroptosis inhibitors, including Fer1, liproxstatin and SRS16-86 bound to the active 
site with a high affinity. Among them, SRS16-86 demonstrated the highest affinity, more than 
one unit higher than baclein and AA —the known inhibitor and substrate of 15LOX, 
respectively. Moreover, we established that different forms of vitamin Es are universally bound 
to the LOX catalytic site. Thus, one of the physiologically significant mechanisms of vitamin Es 
action may be stereospecific liganding of the LOX catalytic site outcompeting the oxygenation 
of free or esterified PUFAs, hence regulating ferroptosis. 
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CL-signaling in apoptosis through interactions of CL/cyt-c (chapter 5): The initiation and 
formation of the cyt-c/CL complex, which leads to cyt-c conformational changes and peroxidase 
activity of cyt-c is pivotal for its role in the early stages of apoptosis. The nature of binding of 
CL to cyt-c, including affinity, stoichiometry and location of binding sites remains unclear 
despite numerous studies.  
To better understand the interplay of different binding sites and multiple modes of 
binding proposed previously, we used molecular modeling —in complement to available NMR 
data— to study the cyt-c/CL interaction and conformational heterogeneity of cyt-c structure. 
Molecular docking identified three possible locations for the interaction of CL with cyt-c, and 
available NMR spectroscopy data provides evidence that all of these sites are actually engaged. 
How can this be possible given the locations on opposite ends of the protein? The answer lies in 
the fact that the interaction of cyt-c with CL has to be seen in the context of the membrane. Our 
CGMD and OPM say that the two binding sites identified by docking are actually one when 
considering the extended size of the membrane and availability of multiple CL molecules within 
and that cyt-c embeds deeply into the membrane. The simulation further supports the notion that 
both, electrostatic and hydrophobic forces combined lead to form a tight CL/cyt-c complex and 
we no longer need to assume a two-step process as in prior models. The ability to bind cyt-c 
simultaneously at two opposing ends of the heme provides a natural path to formation of the 
peroxidase by opening the heme crevice through “pulling” by the membrane. We thus consider 
the simultaneous occupation of the distal and proximal sites as “productive” binding.  
We cannot distinguish if membrane curvature enhances the binding of CL to cyt-c in this 
manner, or if the strain imposed on the membrane by binding is the driving factor for curvature 
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formation. Either way, our results support a model in which cyt-c is partially and stably 
embedded in a locally curved and CL-rich membrane patch.  
The CGMD results are also in good agreement with the NMR and fluorescence results 
with respect to the ratio of CL needed to create a peroxidase. Increasing the CL concentration 
enhances the affinity of cyt-c for the membrane. Remarkably, cyt-c recruits CL to form a cluster 
in the membrane, which demonstrates that multiple CL molecules (not one alone) stabilize the 
cyt-c/CL complex.  
Taking together the conformational studies of cyt-c and interaction studies with CL, we 
propose that gain of peroxidase activity by the cyt-c/CL complex is not a small molecule induced 
effect, but rather is mediated by the interaction with the extensive surface area involved in 
binding to the CL containing membrane bilayer. This has important biological implications for 
modulating cyt-c peroxidase activity. The extensive surface area formed between CL and cyt-c is 
reminiscent of protein-protein interaction interfaces and the inherent conformational flexibility of 
cyt-c identified by the NMR relaxation measurements is crucial for enabling this interaction.  
 
CL-signaling in mitophagy through interactions of CL/LC3 (chapter 5): 1A/1B-light chain 3 
protein mediates both autophagosome formation and cargo recognition during mitophagy. 
However, the mechanism of recognition of injured/damaged mitochondria is not known. Since it 
has been known that CLs are externalized in damaged mitochondria we have hypothesized that 
LC3 may recognize these CLs. To test our hypothesis we employed computational approaches 
(in complement with the available experimental data generated in our group) to predict the CL 
binding site(s) of LC3. Molecular docking analysis predicts CL-binding pockets at the LC3 
surface, where Arg and Lys interact with the negative head groups of CL with two possible 
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conformations. The predicted coordinating amino acids include N-terminal residues of LC3 such 
as Arg 10 and Arg 11 for the top-ranked conformation or Gln 26 and His 27 for the alternative 
conformation. CGMD simulations of 1,000 ns implicate Arg 10 and Arg 11 in the initial 
interactions of LC3 with CL-containing membranes. Then, it was experimentally validated that 
truncation of the predicted CL binding domain or even mutation of the predicted key CL-binding 
residues impaired the mitophagic process. 
Molecular modeling and simulations also predicted that clustering of CL around LC3 may 
serve to stabilize the initial electrostatic interactions, with the embedding of parts of the protein 
into the bilayer through hydrophobic interactions. If this is correct, such a clustering mechanism 
could help ensure that normal transient fluctuations due to lipid transport dynamics do not trigger 
mitophagy until a critical threshold of LC3–CL interaction density is achieved. It is possible that 
in some model systems, the threshold may be modulated by concurrent engagement of other 
cargo-targeting mechanisms. 
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2.0 CHAPTER 2: APPROACHES 
2.1 OVERVIEW 
To address the open questions of each part of this study, we mainly applied molecular docking 
and molecular dynamics simulations. Therefore, in this chapter these two methods will be 
introduced in general. The details of the approaches for each study will be described in the 
pertinent chapter. The other techniques, which were utilized for each particular study, will be 
explained accordingly. 
2.2 MOLECULAR DOCKING 
2.2.1 Protein-Ligand Docking 
Protein-ligand docking is a fast and flexible approach to study the binding pose, bindings sites 
and approximate binding affinity of ligand with proteins. In the current study, we have applied 
lipids/ox-lipids as ligands. Considering the structure of lipids, including polar head group and 
hydrophobic acyl chains, the role of different types of bonds, including electrostatic, 
hydrophobic and hydrogen bonds can be studied. Although many molecular docking software 
and online servers are available, in these studies, lipids were docked to the proteins using 
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AutoDock Vina program, version 1.1.2 [30]. AutoDock Vina is approximately two orders of 
magnitude faster than AutoDock 4 (a similar, comparable and widely-used package), while the 
accuracy of the binding mode predictions has been improved as well. AutoDock Vina is 
benefited from parallelism by using multithreading on multicore machines [30]. Lipids and 
proteins structures were converted from pdb into pdbqt format using MGL Tools [31]. A grid 
box was centered to cover the entire protein, the desired domain or binding site of the protein 
(with maximum dimension of 126 × 126 × 126 points).  
2.2.2 Analysis of the Docking Data 
AutoDock Vina reports the nine lowest energy conformations (called “model #”), which were 
inspected using PyMOL software [32]. The best-fit model has been selected according to binding 
affinity (the highest), visual inspection and clustering the binding models. The residues were 
interacting with lipid —in 5Å distance to lipids— for each model has been extracted. The visual 
inspection on Pymol and residue analysis mainly used to cluster the models. All 9 models have 
been clustered in groups called “binding sites.” The number of models in each pocket divided by 
9 represents the correspondent probability of the binding site. The well-suited model 
demonstrated the highest probability of occurrence.  
2.3 COARSE-GRAINED MOLECULAR DYNAMICS SIMULATIONS 
Molecular dynamics (MD) simulations is a computational method to calculate the time 
dependent behavior of a molecular system [33]. There are now routinely used of MD to 
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investigate the structure, dynamics and thermodynamics of biological molecules and their 
complexes. Molecular dynamics can be run mainly in two resolutions, i. atomistic and, ii. coarse-
grained (CG). Atomistic MD considers all the atoms in the system to build an accurate model. 
CGMD employs approximation to group several heavy atoms in an interaction site called “bead.” 
Considering the relatively large total number of atoms in the systems studied here, which 
comprise several hundred lipid molecules, protein and water and ions, CGMD simulations, rather 
than full atomistic MD simulations, offer advantages of greater length and time scales. 
Moreover, it is the well-suited approach to characterize the dynamic behavior of lipids/ox-lipids, 
and to examine the biophysics of lipids-proteins interactions [34]. 
Initially, all the systems were minimized, before NVT ensemble followed by NPT 
ensemble equilibration runs. According to the system and anticipated properties, each MD run 
was carried out for a certain time period from 100 ns to several μs. A 5-20 fs time step was used 
to integrate the equations of motion depends on the system composition. Mainly, due to presence 
of elastic networks in protein models, which destabilize the system, smaller time step is 
recommended to use. Non-bonded interactions have a cutoff distance of 1.2 nm. The long-range 
Coulomb interactions were calculated via the particle-mesh Ewald method [35]. Temperature 
and pressure were controlled using the Nosé-Hoover [36] and Berendsen [37] algorithms, 
respectively. All production runs are at 310 K and at 1 atm using NPT ensemble. 
2.3.1 Martini Force Field 
In the current study, CGMD simulations were based on the MARTINI force field for 
biomolecular simulations [38]. This model was systematically parameterized based on 
thermodynamic data, especially experimental data for partitioning behaviors of the molecules. 
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The calculated free energies presented in Table 2-1 are compared to experimental values for 
representative small compounds —denoting chemical building blocks. Most of the chosen 
compounds contain four heavy atoms, following the CG model mapping principles. There are 
some exceptions, i.e. building blocks containing three or five heavy atoms, which are included 
either due to the lack of other representative compounds or for comparative reasons.  
 
Table 2-1 Thermodynamic properties of the CG particle types in MARTINI force field a [38]. 
 
a Free energies of vaporization ∆Gvap, hydration ∆Ghydr, and partitioning Gpart between water (W) and organic phases 
(H, hexadecane; C, chloroform; E, ether; O, octanol) are compared to experimental values. The experimental 
vaporization free energy was calculated from the vapor pressure pvap using ∆Gvap ) kBT ln(pvap/kBTcM), where cM 
denotes the molar concentration of the liquid. The experimental free energies of hydration and partitioning were 
compiled from various sources based on log P values. The temperature for the experimental data is in the range 298-
300 K, except where indicated. Simulation data were obtained at 300 K. Experimental properties between 
parentheses are estimates obtained from comparison to similar compounds. The statistical accuracy of the free 
energies obtained from the simulations is ±1 kJ mol-1. b The temperature for the experimental data is 273 K [38]. 
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This force field is the most widely used CG available force field for lipids. Bonded parameters 
are optimized by comparison to lipid conformations sampled with an atomistic force field. 
CGMD simulations of model membranes demonstrate good agreement with atomistic 
simulations as well as available experimental data, especially concerning structural properties 
such as electron densities, area per lipid and membrane thickness [39]. The MARTINI can model 
the behavior of lipid bilayers in terms of the stress profile across the bilayer and its tendency to 
form pores quite consistent with full atomistic simulations [38]. Figure 2-1 illustrate three 
examples of Martini force field for two lipids. 
 
 
Figure 2-1 MARTINI CG mapping of DPPC, cholesterol, and benzene. The prefix “S” denotes ring structures 
[38]. 
 
The MARTINI force field has been extended to protein [40] considering elastic network to 
preserve the protein structure [41], DNA [42] and nanoparticles [43]. The MARTINI group has 
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developed tools to set up CG model for protein, considering elastic networks called “martinize.” 
The current version of martinize is 2.5 that was released in 2015. Moreover, “insane” can be 
used to set up the membrane with various lipid classes and species. However, we mostly used 
Packmol [44] software to building the lipid containing organizations, including bilayer and LD 
various lipid compositions. Packmol is able to pack millions of atoms and grouped them in 
arbitrarily complex molecules inside a variety of 3D regions. The final packing shape can be 
sphere, ellipse, cylinder, plane, or cubic. The only inputs of Packmol are the structure of one 
molecule of each class and the geometrical constraints that each class of molecule must satisfy. 
The complexes easily can be solvated in water, other solvents, or mixtures of them. The packing 
time for MD systems varies from a few seconds to a few hours using a personal computer. 
2.3.2 Analysis of the CGMD trajectories 
Visual Molecular Dynamics (VMD) has been developed by the Theoretical and Computational 
Biophysics group at the University of Illinois and the Beckman Institute in 1995 [45]. VMD is a 
molecular graphics program designed for visualizing and analyzing of molecular dynamics 
trajectories. VMD can display several structures using a wide variety of rendering styles and 
coloring methods. Molecules are shown as one or more “representations.” It is the most capable 
visualizing package with MARTINI force field CGMD simulations. Since the bond definition in 
CGMD simulation is different from full atomistic system, VMD is not able to recognize the 
bonds. Therefore, the script called “cg_bonds.tcl” was employed to represent the bonds in 
MARTINI. The “cg_secondary_structure.tcl” tool was also used to draw protein secondary 
structure in VMD. Various scripts and tools —mainly available in GROMACS package— have 
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been employed to measure divers properties of the system. For instance, to measure the distance 
variation of molecules during trajectory we employed “g_dist” script. 
 
  25 
 
3.0 CHAPTER 3: COMPUTATIONAL STUDIES OF LIPID SIGNALING IN 
A TUMOR ENVIRONMENT 
3.1 SUMMARY 
Lipid droplets (LDs) are ubiquitous and physiologically active organelles regulating the storage 
and mobilization of lipids in response to metabolic demands. Among the constituent LD neutral 
lipids, such as triacylglycerols (TAGs), cholesterol esters (ChEs), and free fatty acids (FFAs), 
oxidizable polyunsaturated molecular species may be quite abundant, yet the structural and 
functional roles of their oxidation products have not been studied. The presence of these 
peroxidized species in LDs of dendritic cells in cancer has been documented. Assuming that 
hydrophilic oxygen-containing functionalities may markedly change the 
hydrophobic/hydrophilic molecular balance, here we utilized computational modeling to test the 
first hypothesis that “lipid peroxidation causes redistribution of lipids between the highly 
hydrophobic core and the polar surface (phospho)lipid monolayer—the area enriched with 
integrated enzymatic machinery”.  
Quantitative liquid chromatography/mass spectrometry (LC/MS) was used because of the 
choice of molecular species and amount of oxidized lipids (ox-lipids) in LDs. Using CG-MD 
simulations we established that oxidation of lipids changes their partitioning, whereby oxidized 
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lipids migrate into the outer monolayer of the LD. In the second part of this chapter, we evaluate 
our second hypothesis that “ox-lipids on the LD surface possibly lead to the formation of 
oxygenated lipid mediators to interact with particular target proteins/enzymes”. Fluorescence 
microscopy of LDs in tumor environment revealed the localization of heat shock protein 70 
(HSP70) on the LD surface. In addition to improving the overall protein integrity, HSP70 plays a 
crucial role in antigen cross presentation (ACP) —essential to anti-tumor immunity. Therefore, 
we employed computational approaches to decipher the mechanism of interactions of oxidized-
lipid-containing LD (oxLD) and HSP70. Although HSP70 rarely interacts with LD, it tightly 
binds on the oxLD surface. We predicted that a β-hairpin motif in N-terminal region of HSP70 is 
responsible for anchoring HSP70 on oxLD surface. 
3.2 SIGNIFICANCE 
Chemical modifications of lipids, mainly peroxidation, generate an array of lipid signals. These 
ox-lipids are mostly chemically reactive compounds. A myriad of oxygenated products can be 
made through three lipid peroxidation mechanisms: (i) autoxidation by free radical reaction, (ii) 
photo-oxidation and (iii) enzyme action. The ox-lipids generated though any of the 
aforementioned pathways mostly convey lethal signals. It has been recently described that the 
presence of ox-lipids acts as signals in cancer to suppress ACP [23, 46]. The lack of knowledge 
and proper tools to screen the lipid peroxidation products to find out those involved in signaling 
processes leave it an open and highly active research area. Additionally, discovering the 
mechanism of action of ox-lipids in ACP suppression using the conventional methods is hard to 
achieve.  
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Here, we utilized computational methods to unearth the role of oxidized lipid in ACP 
suppression. To this end, we initially described the dynamics behavior of oxidized lipids in LD 
using molecular dynamics (MD) simulations. Since MD simulation provides the 
thermodynamically favored state of the system (local or global minima in free energy landscape), 
it is a capable method to predict structural changes due to the presence of ox-lipids in LDs. 
Subsequently, we examined the interactions of ox-lipids and HSP70 —a protein that is known to 
be involved in ACP. Our computer modeling data proposed that HSP70 recognizes the structural 
changes imposed by oxidized lipids in LD. 
3.3 INTRODUCTION 
Lipid droplets (LDs) are dynamic cytoplasmic organelles that can be found in nearly all 
eukaryotic cells [47]. They play important roles during changes in metabolism of intracellular 
neutral lipids, particularly free fatty acids [48]. Not surprisingly, LDs have been related to 
dyslipidemias that are characteristic of a number of chronic diseases, including obesity, diabetes, 
atherosclerosis, and the metabolic syndrome [49].  
The structural organization and function of LDs are determined by the physico-chemical 
intermolecular interactions of neutral lipids with each other in the hydrophobic core and with 
phospholipids, particularly phosphatidylcholine (PC), as well as with proteins embedded in the 
surface monolayer ( Figure 3-1A). The number of PCs and other polar molecules available to 
cover sufficient surface area of the LD defines its overall size in the aqueous cytosolic 
environment [50]. Moreover, the surface monolayer, along with its enzymatic machinery and 
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corresponding adapter proteins, is viewed as a locale of metabolic conversions of constituting 
LD lipids ( Figure 3-1B) [51]. 
 
 
 Figure 3-1 Lipid droplet structure.  
A. LD hydrophobic core is separated from the aqueous cytosol by a monolayer of surface phospholipids. B. LDs are 
decorated with specific surface proteins localized on the LD surface. Neutral lipids (green) and LD-associated 
proteins (red) visualized by fluorescence microscopy (adapted from [47]). 
 
In addition of the known functions of LDs, e.g. lipid storage, recently many novel roles of LDs 
have been emerged. Figure 3-2 shows a model of the emerging roles of LDs, including their role 
in immunity and host-pathogen interactions [52]. These functions highlight the role of lipid 
signaling through LDs in several immune-related pathways. It has been shown that LDs are 
involved in bacterial/viral infections and antigen-cross presentations (ACP). Although the details 
of former have been studies, how LDs participate in cross-presentation is not clear. 
Among the neutral lipids comprising the hydrophobic core, TAGs, ChEs, FFAs—in 
different proportions—are the most prominent components of LDs [53]. While the composition 
and molecular identities of neutral lipids are influenced by extra- and intracellular metabolic 
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demands, a significant proportion of these molecules may be represented by polyunsaturated 
species with two or more double bonds [54]. This suggests that the vulnerability to oxygenation 
may lead to the appearance of polar functionalities in the hydrophobic acyls, shifting the 
molecular hydrophobic/hydrophilic balance [55], and causing significant modifications of LDs 
organization. Indeed, the presence of oxygenated TAGs, ChEs, and FFAs in immunologically 
impaired dendritic cells from tumor-bearing animals and cancer patients has been documented 
[23, 46]. 
Reasoning that these oxidative modifications of polyunsaturated fatty acid (PUFA)-
containing LDs may be widespread, here we undertook a CGMD study of the effects triggered 
by the appearance of oxidized TAGs (oxTAGs) in LDs. Given the myriads of possible 
diversified oxygenated TAGs, our choice was based on the LC-MS-based detection of these 
species in dendritic cells of tumor-bearing mice [56]. We demonstrate that oxTAGs affect the 
hydrophobic–hydrophilic balance of LDs, leading to disturbances in phase separation between 
the neutral lipid core and the phospholipid outer monolayer. Therefore, they possibly can be 
recognized by proteins/enzymes on LD surface. Recent experimental data demonstrated that 
HSP70 localizes on LDs present in tumor environment, but not in wild type cells. Moreover, it is 
known that HSP70 is involved in exogenous antigen processing by facilitating their translocation 
to the proteasome [57]. We then hypothesized that HSP70 recognizes ox-lipids on oxLD surface. 
Hence, we have studied the interactions of HSP70 and oxLDs via molecular modeling to test our 
hypothesis and decode the mechanism of action of ox-lipids in ACP suppression. 
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Figure 3-2 Novel emerging roles of LDs in immunity.  
1. LDs participate in the biosynthesis and secretion of inflammatory mediators (black pathways). In this pathway 
accumulation of LDs can be triggered through Toll-like receptor (TLR) dependent manner. Eicosanoids 
prostaglandin E2 (PGE2) or leukotriene B4 (LB4) — cyclooxygenase (COX) or lipoxygenase (LOX) products of 
arachidonic acid metabolization— are released that potent inflammation mediators and immunity modulators. 2. 
Due to viral infections (red pathways), cells respond by producing IFN, which induces the expression of IFN-
stimulated factors. Viperin, one of such factors, localizes to LDs, exerts antiviral activity against a range of viruses. 
3. Involvement of LD in antigen-cross presentation (blue pathways). Upon IFNγ stimulation, a family of IFN-related 
GTPases (IRGs) proteins are induced. A member of this family, Irgm3, localizes to the ER and to LDs where it can 
interact with PLIN2 (ADRP). Irgm3 is essential for IFNγ-induced LD biogenesis and for antigen-cross presentation 
to CD8+ T lymphocytes (MHC-I) (adapted from [52]). 
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3.4 APPROACH 
3.4.1 Setup and Optimization of CG Model of LD 
To decipher the possible mechanism of ACP suppression, the experimental data were leveraged 
to set up models of LDs containing oxygenated lipid productions. The structural and 
conformational changes in LDs were assessed using CGMD simulations. To set up a LD system, 
the size of the LD is a crucial parameter. According to the study by Penno et al. [58] about the 
size of LD and the ratio of triacylglycerols/ phosphatidylcholine (TAG/PC) lipids, very small LD 
poorly represent the real system (LD size: 100 nm – 100 μm). As the authors proposed, the ratio 
of TAG/PC increases by increasing the LD radius (Eq. 3-1): 
 
TAG = 0.215nm-3 × a × (r − 2.5)3 × r-2 × PC    (Eq.3-1) 
 
where a is the surface area per PC molecules in nm2 (about 0.7 nm2 is acceptable for different 
PC) and r is the LD radius measured in nm. To create the optimized LD model, we initially built 
CG models of POPC and TAG (Figure 3-3A). Then, we investigated the effect of phospholipid 
to TAG relative ratios on the shape of the resulting LD model (Figure 3-3B). The four different 
POPC:TAG ratios of 1, 2, 3, and 4 were chosen and subjected to simulation. The resulting shapes 
of the LDs with different lipid compositions, as inspected after 50 ns equilibration, are 
summarized in Table 3-1. A model that shows spherical characteristic shape and two distinct 
phases, containing 200 TAG and 400 POPC molecules (r = ~6.5 nm), has been chosen to 
evaluate role of oxTAGs on LD structure. 
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Table 3-1. LDs with four different lipid compositions and their shapes after 50 ns equilibration.  
Composition POPC:TAG 
Ratio 
Shape 
POPC TAG 
800 200 4 Not Spherical - asymmetric  
600 200 3 Close to spherical – asymmetric  
400 200 2 Spherical 
200 200 1 Close to spherical – asymmetric – 
POPCs did not cover the surface 
thoroughly 
 
 
Figure 3-3 Effect of POPC:TAG ratio on LD shape.  
A. CG model of triacylglycerol (upper panel) and POPC (lower panel). Color guide: cyan: ~4 carbons with saturated 
bonds; brown: ~4 carbons with one unsaturated bonds; pink: glycerol group; green: phosphate group; blue: choline 
group. B. CGMD snapshot of 50ns equilibrated lipid droplets structure containing 200 TAG and I. 800 POPC, II. 
600 POPC, III. 400 POPC and IV. 200 POPC. Color guide: blue beads: choline group of POPC, transparent yellow: 
POPC; cyan: acyl chain of TAG, pink: head groups of TAG. 
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3.4.2 CGMD Simulations of LD Containing oxTAGs 
The effects of adding oxidatively truncated- and dihydroxy-TAGs to the LD core on lipid 
partitioning in LDs were evaluated using CGMD simulations with the optimized LD model. Two 
different levels of oxidation have been assessed, 5 and 10 mol% oxTAGs. As controls, we 
simulated LDs without adding any oxidized TAG species. Thus, five fully hydrated systems 
were set up (Table 3-2).  
 
Table 3-2. Composition of LDs used to study the role ox-TAGs on LD structure via CGMD simulations.  
System 
Composition 
Dihydroxy-TAG  
Truncated-
TAG  
TAG POPC 
5 mol% dihydroxy-TAG  10 -- 190 400 
10 mol% dihydroxy-TAG  20 -- 180 400 
5 mol% truncated-TAG  -- 10 190 400 
10 mol% truncated-TAG  -- 20 180 400 
Control -- -- 200 400 
 
For each of the five systems, three different simulations were carried out by equilibrating them 
with three different random seeds to produce different initial velocities and thus different 
trajectories. In total, 15 simulations were run, 2 μs each. 
3.4.3 Study Interactions of oxLD and HSP70 
Then, a combination of sequence and 3D structure analysis, molecular docking and CGMD 
simulation were used to study the mechanisms of interaction of oxygenated products and HSP70. 
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Sequence and 3D structure alignments: Since the only available full-length structure of HSP70 
belongs to E. coli (PDB ID: 2KHO) [59], the identity and similarity of this structure with human 
HSP70 were studied. The sequence alignment was carried out using the protein blast option of 
the BLAST server [60].  
Molecular docking: The oxygenated truncated TAG (18:2/C9-OND/18:2-TAG) was docked to 
the crystal structure of E. coli HSP70 (PDB ID: 2KHO). Since the protein is not fitted in a grid 
box, it was split into two pieces, including the N-terminal ATPase domain (NAD) as one piece 
and the substrate binding domain (SBD) and C-terminal domain (CD) as another piece. In both 
cases, the top-ranked binding pose with the highest binding affinity was reported 
CGMD simulations: Two types of LD have been set up, with and without oxygenated products, 
called oxLD and LD respectively. Here the oxLD model contains oxTAG (18:2/C9-OND/18:2), 
oxTAG (18:2/C9-OND/18:2) and 4-Hydroxynonenal (HNE) with corresponding concentrations 
of 7 mol%, 1 mol% and 2 mol%. E coli. The HSP70 chaperon was modeled based on the 
MARTINI force field. The elastic network was applied as a structural scaffold to maintain the 
overall shape of the protein [61]. For each of the two systems, three different simulations were 
performed by equilibrating them with three different alignments of HSP70 versus LD to consider 
the effects of protein orientation on the trajectories. In total, 6 simulations were run, 2 μs each. 
Initially, each system was minimized for 20 ps, before NVT and NPT ensemble equilibrations. A 
20 fs time step was used to integrate the equations of motion.  
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3.5 RESULTS 
3.5.1 Development of a CGMD Model for LD 
CGMD modeling has been successfully applied to studies of lipoproteins – HDL and LDL [62-
64], but not generic LDs. We therefore first developed and optimized a model for a LD without 
oxTAGs. In the initial simulations, we assessed the effects of varying the POPC:TAG ratios at a 
fixed number of TAGs on LD organization after 50 ns equilibration. The LDs shape was strongly 
dependent on the number of POPC molecules present. When the number of POPC was too high, 
elongated shapes were observed, and when the number of POPC was too low, there was not 
sufficient POPC to cover the surface of the LD.  
Only at a POPC:TAG ratio of 2 was the characteristic spherical shape and two 
distinctively separated phases of core and surface monolayer were achieved. This equilibrated 
arrangement of LDs remained stable within 2 μs (Figure 3-4A) at which point several TAG 
molecules were found to be partitioned from the hydrophobic core into the more polar regions of 
the PC monolayer. Analysis of 1D and 2D number density graphs (Figure 3-4B and C, 
respectively) along the z-direction established that the approximate boundary of the LD core and 
monolayer was located at r= ~4 nm. 
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Figure 3-4 CG-MD simulations of lipid droplets containing POPC in monolayer and TAG in the core, without 
any oxidized lipids (control system).  
A. CG-MD snapshot of the control system at t=0ns (left) and t=2μs (right). Color guide: thin green line: POPC; thick 
yellow line: TAG. B. 1D number density of lipids along the z-axis of the simulation box. C. 2D number density 
maps of POPC (left) and TAG (right) molecules along the z direction.  
 
3.5.2 Effects of Lipid Oxidation on Lipids Dynamics in LD 
To study the effect of lipid oxidation on lipid dynamics in LD, we used the LC-MS data to guide 
us in the choice of molecular species and the amounts of oxidized lipids to be modeled. The LC-
MS data confirmed the presence of several oxygenated TAGs including truncated species. LDs 
containing two representative types of oxidized TAGs—with hydroxy-LA and oxidatively 
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truncated LA—at two different oxidization levels (5 and 10 mol% of total TAGs) have been 
employed in the CG-MD simulations (Figure 3-5).  
 
 
Figure 3-5 Initial and final configurations of LDs containing oxTAGs determine that significant amount of 
oxidized species move to the monolayer.  
A. CG models of oxidized species. Color guide for CG model of oxidized TAG: cyan: ~4 carbons with saturated 
bonds; brown: ~4 carbons with one unsaturated bonds; pink: glycerol group; purple: part of the acyl chain in a 
dihydroxy-TAG containing –OH group; orange: part of acyl chain in a truncated-TAG containing =O group. B. and 
C. Initial and final configurations of LDs structure containing 5mol% (left) and 10mol% (right) trauncated- and 
dihydroxy-TAGs. Color guide for LD structure: thin green line: POPC; thick yellow line: TAG; thick red line: 
oxTAG; brown sphere: oxidized bead.  
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When compared to non-oxidized TAGs, we found that a significantly larger amount of 
oxidatively modified TAGs of both types partitioned into the phospholipid monolayer. 1D 
number density graphs of oxidatively truncated TAG displayed two shoulders on both sides of 
the graph, clearly revealing their tendency to partition into the PC monolayer (Figure 3-6A). 2D 
number density maps of oxTAGs uniformly confirmed their preferred redistribution from the 
hydrophobic core into the more polar surface monolayer (Figure 3-6B). 
 
 
Figure 3-6 Number density of oxTAGs in the systems containing truncated-TAGs along the z-axis of the 
simulation box.  
A. 1D and B. 2D number density of oxTAGs for systems containing 5 mol% (left) and 10 mol% (right) oxygenated 
truncated-TAGs. 
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Similar behavior was observed for LDs containing dihydroxy-TAG species (Figure 3-7). To 
compare the dynamics of non-oxidized TAGs and oxTAGs, 2D number density maps of TAGs 
for the entire systems were generated (Figure 3-8). They demonstrated that non-oxidized TAGs 
were preferentially located in the core region.  
 
Figure 3-7 Number density of oxTAG in systems containing dihydroxy-TAGs along the z-axis of the 
simulation box.  
A. 1D number density of oxTAGs in system containing 5mol% (left) and 10mol% (right) dihydroxy-TAGs. B. 2D 
number density of oxTAGs in system containing 5mol% (left) and 10mol (right) dihydroxy-TAGs. 
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Figure 3-8 2D number density map of non-oxidized TAG molecules.  
2D number density of four systems containing, A. 5mol% truncated-TAGs (left) and 5mol% dihydroxy-TAGs 
(right); B. 10mol% truncated-TAGs (left) and 10mol% dihydroxy-TAGs. 
 
Figure 3-9 oxTAGs are located close to 
the surface, but below the head groups 
of POPC molecule. 
A. CG-MD representation of TAGs and 
oxTAGs in POPC monolayer of LD 
containing 5mol% and 10mol% truncated-
TAGs. TAGs and oxTAGs are located 
below the head groups of POPC 
molecules (blue spheres represents 
choline groups). They do not have access to water molecules directly; B. The final distribution of oxTAGs (TAGs 
removed for clarity). oxTAGs were distributed randomly, without detectable clustering. Color guide: thin green line: 
POPC; thick yellow line: TAG; thick red line: oxTAG; brown sphere: glycerol bead; green sphere: oxidized bead. 
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Figure 3-10 Distance of center of mass (COM) of TAG/oxTAG to choline groups of POPC (LD surface) vs. 
time; in 5mol% truncated-TAG system, A. TAGs, B. oxTAGs.  
Three TAG and oxTAG molecules were randomly chosen to calculate their COM distance to choline groups of 
POPC —representing LD surface— was calculated. Averaged values of COM of these molecules show that 
oxTAGs preferentially stay for longer time in the proximity of the phospholipid monolayer over the entire trajectory 
while TAGs are not stable in the outer monolayer and fluctuate between the two LD phases.  
 
The expanded view of the final configurations showed that TAGs and oxTAGs in the monolayer 
were located below the head groups of POPC molecules (Figure 3-9 A) and were distributed 
arbitrarily, without detectable clustering (Figure 3-9 B). The dynamics of several randomly 
selected oxTAGs and TAGs revealed that unlike TAGs, the oxTAGs preferred to remain in the 
monolayer (Figure 3-10). 
3.5.3 Interactions of Oxidized LD and HSP70 
According to our data, addition of hydrophilic oxygen-containing functionalities during 
peroxidation of polyunsaturated fatty acid residues of lipid molecules may markedly change the 
hydrophobic/hydrophilic balance of the latter. This may dramatically affect the structural 
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organization of lipid-enriched domains of membranes and lipid droplets.  Our previous work has 
established the accumulation of neutral lipids and formation of lipid droplets in DC of tumor-
bearing animals and cancer patients [24]. This has been accompanied with the important 
disturbances of one of the major DC functions – cross-presentation of antigens [23] whereby not 
only higher levels of neutral lipids and LDs but the obligatory presence of elevated levels of 
peroxidized TAGs, peroxidized ChEs and peroxidized FFAs were necessary for the characteristic 
immune-deficiency of DCs in cancer [24].  
Based on the identified chemical structure of peroxidized neutral lipids accumulating in 
lipid droplets of DC affected by tumor-derived factors, we utilized computational modeling to 
decipher molecular mechanisms through the peroxidation products may affect the antigen cross-
presentation. Three oxidatively truncated oxTAG species were examined in LD, including two 
TAGs species with esterified C9-ONA, as well as with 4-Hydroxynonenal (HNE). Using CG-
MD simulations we endeavored to explore the motional behavior and preferred localizations of 
oxTAGs within lipid droplets. CG-MD demonstrated the higher likelihood of oxTAGs —versus 
non-oxidized lipids— to leave the LD hydrophobic core and re-locate into the phospholipid 
monolayer on the LD surface [65].  This migration of oxTAG to the LD outer monolayer makes 
them accessible for interactions with multiple cytosolic proteins, including those involved in 
antigen cross-presentation.  Therefore, we were interested in exploring possible interactions of 
oxTAG with HSP70, one of the key-proteins in the foreign antigen processing [57]. To this end, 
we employed a combination of molecular docking with CG-MD simulations. 
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Figure 3-11 Molecular docking of truncated TAG to HSP70 domains. 
Molecular docking shows a higher affinity interaction of the oxygenated truncated TAG with N-terminal ATPase 
domain (NAD) as compared with the substrate binding domain (SBD) or C-terminal domain (CD); Note the 
differences in binding energies -6.1 kcal/mol vs. -4.9 kcal/mol, respectively. 
 
The molecular docking showed that oxTAG with esterified C9-ONA strongly interacted with N-
terminal ATPase domain (NAD) of HSP70 with a binding energy of -6.1 kcal/mol (Figure 3-11), 
in contrast to a much weaker binding to the substrate binding domain (SBD) or C-terminal 
domain (CD) (binding energy of -4.9 kcal/mol).  Thus, oxTAG displayed a higher affinity for the 
N-terminal domain of the HSP70 chaperon.  
Next, we utilized CGMD simulations to explore the interactions of HSP70 with LD and 
oxLD. Since the full-length structure of human HSP70 has not been published, we employed the 
structure of E coli. HSP70 structure. The sequence analysis and alignment showed 46.5% 
identity and 26.3% similarity, which represent a high degree of resemblance. The CG model of 
E. coli HSP70 was built based on the MARTINI force field with application of the elastic 
network to maintain the overall shape of the protein [61]. To mitigate the effect of the protein 
alignment on the interactions with LD, the initial orientation of HSP70 was varied for each run to 
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generate three independent trajectories. We assessed the distance from center of mass of HSP70 
to the surface of LD during 2 μs (Figure 3-12 A&B). In all three tested cases, the CGMD 
simulations demonstrated HSP70 interaction with oxLD – in contrast to only one out of three 
trials with LD.  This reflects a higher probability of interactions of HSP70 with oxLD than with 
LD. Among three oxLD systems, HSP70 remained tightly bound to the surface of two oxLD 
(namely, OX1 and OX2 runs) by the end of the simulations. Interestingly, HSP70 was positioned 
on the oxLD surface in the same orientations for both OX1 and OX2 (Figure 3-12C).  
The typical final configurations of the interactions of HSP70 with oxLD for OX1 and 
OX2 simulations are shown in Fig. 1D. The residue analysis of the final configuration of these 
simulations predicted three binding sites on HSP70 that were involved interactions with 
oxygenated lipid products.  Binding site 3 penetrated almost 15 Å into the depth of the LD 
phospholipid monolayer to get in close proximity to the oxygenated lipids.  
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Figure 3-12 Distance analysis of HSP70/oxLD trajectories.  
A&B. HSP70 interacts with oxLD in all three CGMD simulations during 2 μs runs, in which the initial orientations 
of HSP70 were varied as compared with the interactions in only one out of three runs with LD. C. Two out of three 
CGMD simulations (OX1 and OX2) showed strong interactions of HSP70 and oxLD throughout and until the end 
resulting in the similar final (at t = 2 μs) orientations. 
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The secondary structure of this binding site represents β-hairpin motif, which may facilitate the 
HSP70 positioning on the LD surface (Fig. 1E). Notably, all three binding sites contain at least 
one lysine residue that can chemically react with lipid oxidation products to yield covalent 
adducts such as Schiff bases [66]. Thus it is likely that interactions of HSP70 with LD containing 
peroxidation products will trigger “lipidation” of the protein that will “anchor” the protein to the 
LD. 
 
Figure 3-13 HSP70 anchored on oxLD surface using a sheet-turn-sheet like domain  
A. Typical final configuration of CGMD simulations show that E. coli HSP70 interacts mainly with oxygenated 
products, including oxTAGs and HNEs present in oxLD. B. The main binding site responsible for the anchoring of 
HSP70 to the LD surface contains a sheet-turn-sheet motif and a positively charged Lys294 - likely involved in the 
covalent interactions with oxTAG. 
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3.5.4 Comparison with Experimental Results 
Experimental results informed the computational model in several ways. First, to study the 
structural role of the oxygenated lipids in LD structure, we set up CGMD models of non-
oxidized and oxidized LDs based on quantitative liquid chromatography/mass spectrometry 
(LC/MS). Specifically, the LC/MS data was used to choose the molecular species and amount of 
oxidized lipids (ox-lipids) in our model [65, 67].  
Next, the study of the interaction of HSP70 with LD was based on experimental results. 
Fluorescence microscopy had shown that HSP70 co-localizes with LDs present in the tumor 
environment. Therefore, we studied interactions of HSP70 with oxLD to investigate how HSP70 
mediates the role of ox-lipids in the ACP pathway.Our modeling data of the interactions of 
HSP70 and oxygenated TAGs suggested the possibility of covalent binding of HSP70 with 
oxTAGs, a finding that was not anticipated by the experimental studies. To validate my 
prediction, my laboratory colleages assessed covalent association of HSP70 with oxTAGs 
generated by pre-incubation of arachidonic acid (C20:4)-containing TAGs with myeloperoxidase 
by SDS-PAGE. This resulted in the detection of oxygenated adducts detectable in the monomeric 
form of HSP70 (70 kD) as well as with high molecular weight protein aggregates present in the 
gel (confirmed by silver staining). High molecular weight aggregates formed after interaction of 
HSP70 with the oxygenated products. Aggregated high molecular weight protein oligomers are 
characteristic products formed as a result of crosslinking of amino acid residues with lipid 
peroxidation products. This finding strongly validates my prediction. 
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3.5.5 Discussion and Conclusions 
LDs are essential for the regulation of lipid homeostasis in both adipose and non-adipose tissues 
[49]. The dynamic features of LDs as organelles capable of changing their neutral lipids content 
in adaptive response to metabolic demands and conditions is maintained by a large number of 
catabolic and anabolic enzymes. These enzymatic assemblies are localized on the LD surfaces, 
and play a role in the regulatory interface between the hydrophobic core and the aqueous cytosol, 
as well as in membranes of other organelles, particularly endoplasmic reticulum (ER) and 
mitochondria [68]. Amphiphilic phospholipids, adsorbed at the interface between the interior of 
the LD and the surface as a monolayer, are essential for decreasing LD surface tension, creating 
high bending elasticity, stability, and most importantly allowing the accommodation and 
organization of the enzymatic lipid-metabolizing machinery [69]. The thorough control over the 
amounts of interface molecules between the two phases is critical to the cellular function of LDs. 
Notably, oxidizable PUFA-TAGs may constitute a significant fraction of the total amount 
of neutral lipids in LDs. The available global lipidomic analysis of DCs present in tumor 
environment indicated that >60% of the total lipids comprised the oxidizable species. 
Remarkably, we detected significant amounts of oxidized TAGs that harbored oxygenated 
functionalities such as mono-oxygenated and di-oxygenated derivatives as well as oxidatively 
truncated TAG species. While their origin and mechanisms of formation remain to be elucidated, 
the appearance of TAGs with these polar oxygenated groups in the hydrophobic core on LDs 
may act as an important factor shifting the equilibrium properties of the LD where the perturbed 
balance between hydrophobic and hydrophilic groups results in altered distributions of the 
constituent lipids. 
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While lipid peroxidation has not been studied in LDs, their effects on membranes have been 
investigated previously [22, 70]. In particular, it has been shown that the addition of polar 
oxygen atom(s) to fatty acyl chains of phospholipids causes reorientation of the modified acyl 
chain, and results in its protrusion into the aqueous phase like “whiskers” [22, 70]. This finding 
suggests that peroxidation increases the affinity of hydrophobic lipid acyls for the polar aqueous 
phase. Indeed, our computational modeling of LDs containing oxidized neutral lipids indicated 
that the presence of oxTAGs inside the hydrophobic LD was thermodynamically unstable, 
resulting in their migration toward the hydrophilic surface. Both oxidatively-truncated TAGs and 
dihydroxy-TAGs disturbed the stability of the two distinctive LD phases, and their presence 
causes partitioning of oxTAGs into the phospholipid monolayer. Notably, increasing the content 
of oxTAGs from 5mol% to 10mol% enhanced the partitioning of oxTAGs into the POPC 
monolayer.  
As a lipid storage organelle [71, 72], the neutral lipids deposited in the LD hydrophobic 
core should have access to lipases that facilitates their metabolism. Walther and Farese [72] 
hypothesized that this can be achieved via: i) an “extension” of lipases through the phospholipid 
monolayer to reach the required bonds of neutral lipids, or ii) penetration of neutral lipids in the 
PC monolayer. Our computer modeling data are compatible with the second hypothesis. Indeed, 
we found that a small fraction of non-oxidized TAGs also moved to the POPC monolayer. This 
is in line with a previous study [62] showing that in HDL cholesterol esters (ChEs) were also 
able to penetrate into the outer monolayer to reach to the ChE transferase protein, apolipoprotein 
A-1, on the surface. 
The close-up snapshots of LD after 2 μs (Figure 3-9) demonstrated the presence of both 
oxTAGs and TAGs in close proximity to the LD surface, immediately below the choline and 
  50 
phosphate groups of POPC molecules. This suggests that the “sensitive” bonds of these TAGs 
may be accessible to LD associated proteins. Notably, although both TAGs and oxTAGs are 
capable of moving into the POPC monolayer, the latter preferentially stay for a longer time in the 
proximity of the phospholipid monolayer over the entire time of the trajectory, while the former 
are not stable in the outer monolayer and fluctuate between the two LD phases.  
Are the dynamics of oxTAGs and their partitioning into the LD monolayer 
physiologically relevant? The accumulation and presence of oxidized neutral lipids in the LD 
monolayer suggests their potential roles in lipid mediator signaling networks. Indeed, lipolysis of 
oxTAGs should generate oxFFAs – precursors of lipid mediators.  In spite of the fact that this 
study presents a simplified model of oxidized lipid dynamics in LD, our data suggest novel 
mechanisms of biochemical processing of TAGs and oxTAGs that raise challenging biophysical 
questions.  
Our CG-MD demonstration of preferred partitioning of oxidatively modified neutral 
lipids to the surface area is based on a model which corresponds to a relatively small LD size 
compared to the actual LD dimensions. Thus, our model depicts a higher curvature and a higher 
surface pressure at the interface, which can be addressed in future studies.  
These peroxidized lipid species on LD surface could be located in the close molecular 
proximity to the contact sites with neighboring organelles, such as lysosomes. As a result of this 
proximity, the direct transfer of peroxidized lipids from LDs into lysosomes becomes possible. 
The exact mechanisms and pathways, through which these peroxidized lipids affect the cross 
presentation process, remain to be elucidated. 
We found that TAGs with oxidatively modified PUFA constitute ~10% of the total 
amount of these neutral lipids in LDs in DCs in cancer [73]. The appearance of polar oxygenated 
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groups in TAGs in the hydrophobic core of LDs may be an important factor causing 
redistribution of LD lipids from the core towards the surface monolayer. Noteworthy, the 
hydrolysis of oxTAG by the LD lipases yields polyunsaturated non-oxidized and oxygenated 
FFA [74]. The latter can be utilized as precursors of lipid mediators with important signaling 
functions [75].  
Among the many proteins involved in ACP, heat shock proteins —HSP70 and HSP90— 
play roles in translocation of exogenous antigens, either from the ER-endosome to the cytosol or 
from the cytosol to the proteasome. According to recent data that described the localization of 
HSP70 on LD surface in a tumor environment, we explored the interactions of HSP70 with 
oxLD and LD. We demonstrated that ox-lipids on LD surface are recognized by HSP70. Among 
three candidate oxTAGs-binding sites of HSP70, the site containing a β-hairpin motif deeply 
penetrated into the oxLD monolayer. We additionally proposed that these interactions might be 
irreversible due to possible covalent binding between aldehyde groups of ox-lipids and lysine 
residues present in the ox-lipid-biding site of HSP70. The anchoring of HSP70 on oxLD surface 
deviates HSP70 from its original function in ACP. In conclusion, using computational 
approaches, we suggest a novel mechanism of ACP suppression through interactions of HSP70 
and oxLD. Therefore, we propose a biological role and pathological significance of oxidized 
neutral lipids accumulation at the LD surface, which block the antigen cross presentation. 
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4.0 CHAPTER 4: COMPUTATIONAL STUDIES OF LIPID SIGNALING IN 
FERROPTOSIS 
4.1 SUMMARY 
Ferroptosis is a newly discovered cell death pathway that is characterized by high levels of lipid 
hydroperoxides. Although the exact lipid peroxidation pathway is ill defined, recent findings 
indicated the involvement of lipoxygenases (LOXs), particularly, 15LOX. Here, a combination 
of computational approaches was used to identify preferred phospholipid (PL) substrates for 
LOXs. The catalytic mechanism of LOXs was studied as well. Using comprehensive molecular 
docking modeling, the binding poses and the binding affinities of various small molecules, 
including, esterified lipids and LOX inhibitors were assessed. The data revealed high affinity 
binding of vitamin E at the LOX active site compared to arachidonic acid (AA). Among 
phospholipids (PLs), phosphatidylethanolamine (PE) and phosphatidylinositol (PI) were 
predicted as the most likely substrates for 15LOX-2. Coarse-grained molecular dynamics 
(CGMD) simulations were applied to study the interactions of 15LOX-2 with the membrane 
composed of eight lipid species. Analyzing the final configuration of the bound 15LOX-2 in the 
membrane presented the key lipids and the main protein’s residues involved in these interactions. 
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CGMD simulations also provided insight into the protein’s orientation in the membrane. These 
data have been supported using orientation of protein in membranes (OPM) analysis. 
4.2 SIGNIFICANCE 
Ferroptosis is an iron-dependent cell death pathway discovered in 2012 by Dixon et. al. [76]. It is 
characterized by iron overload and enhanced levels of lipid hydroperoxides, leading to caspase- 
and necrosome-independent cell death. So far, glutathione peroxidase 4 (GPX4), a critical 
antioxidant enzyme, has been identified as a key regulator of this pathway. Depletion of 
intracellular glutathione results in impaired GPX4 function that is characterized by accumulation 
of lipid peroxides, leading to lipid peroxidation mediated cell death. Thus, identification of the 
pathways involved in lipid peroxidation is crucial for understanding the mechanism of 
ferroptosis. Current knowledge in this area implicates a central role of 15LOX in ferroptosis. 
Using computational approaches, we examine here, the mechanism of 15LOX activation, using  
its natural substrate, PUFAs, and also inhibitors. The molecular docking and molecular dynamics 
simulations data revealed the membrane binding mechanism for 15LOX, including the domain 
responsible for recognizing the hydrophobic core of the bilayer. Application of such 
computational approaches is expected to make significant contributions to our understanding of 
LOX-driven PL peroxidation signaling in ferroptosis.  
  54 
4.3 INTRODUCTION 
4.3.1 Ferroptosis 
Multicellular eukaryotes have perfected the programmed cell death pathways to optimize tissue 
homeostasis, immune and stress responses, as well as embryogenesis [77]. These programs have 
also been shown for prokaryotes through quorum sensing, thus making cell death pathways 
paradoxically essential across all life forms. One of the most recently identified redox programs 
of cell death is ferroptosis [76]. It is genetically, biochemically and morphologically distinctive 
from apoptosis, necrosis, and autophagy (Figure 4-1) [78]. It has been documented that 
oncogenic RAS-selective lethal small molecules (RSLs) such as erastin activate this iron-
dependent cell death pathway (Figure 4-2). On a global scale, redox ferro-ferric cycling of iron 
by microorganisms controls the planetary fate of this element in the environment [79]. In 
eukaryotic cells, the same electron donor-acceptor propensities of iron that define its vital role in 
normal physiology and metabolism facilitate the ferroptotic cell demise programs [76].  
Ferroptotic death program is activated by a disruption in the coordinated cross-talk 
between two major redox systems: thiols and lipid peroxidation. It has been postulated that a 
combination of GPX4/GSH deficiency and activation of one or more putative iron-containing 
enzymes generate oxygenated lipids that act as the proximal signals for ferroptotic cell death 
[80].  
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Figure 4-1 Ferroptosis is distinct from apoptosis, necrosis, and autophagy.  
Regulated cell death (RCD) pathways can be classified by whether or not they are caspase dependent. Ferroptosis is 
a caspase-independent form of RCD and are highly immunogenic (adapted from [78]). 
 
Among the specific features of ferroptosis, there are: i) deficiency/inactivation of phospholipid 
hydroperoxides metabolizing enzyme, GPX4 [81, 82]; ii) sensitvity to iron chelators [76]; iii) 
rescue by long-chain polyunsaturated fatty (arachidonic) acid specific acyl-CoA synthase (Acsl4) 
[83] and lysophospholipid acyl transferase [83], and iv) suppression by vitamin E [76, 81]. Thus, 
the process of lipid peroxidation is central and specific to the execution of ferroptosis [76, 80, 
82]. 
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Figure 4-2 Ferroptosis is similar to glutamate-induced excitotoxicity. 
It is triggered by inhibition of cystine uptake. Iron chelators are the primary inhibitors of this newly identified cell 
death pathways (from http://being-bioreactive.com/). 
 
In spite of the numerous indications pointing to the lipid involvement in ferroptosis neither has 
direct evidence for lipid peroxidation, nor has the nature of oxygenated lipid species triggering 
cell demise been identified. Recent data suggest that oxygenated species of arachidonoyl- and 
adrenoyl-diacyl-phosphatidylethanolamines (AADiPEox and AdADiPEox) are strong predictive 
biomarkers of ferroptotic cell death in vitro and in vivo (unpublished data). It has further been 
documented that the lipoxygenases  are key players in the ferroptosis cell death pathway.  
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4.3.2 Lipoxygenases 
LOXs are a family of non-heme, iron-containing enzymes that catalyze the dioxygenation of 
polyunsaturated fatty acids in lipids containing a cis,cis-1,4-pentadiene structure. The 
phylogenetic tree of LOX family enzymes is shown in Figure 4-3 [84]. The number assigned for 
each LOX is based on the specificity of the enzyme acting on its substrate. For instance, 12-LOX 
oxygenated arachidonic acid (AA) at carbon-12. “R” or “S” is used to specify the 
stereochemistry for these enzymes (12R-LOX or 12S-LOX).  
The plant and animal LOXs have many common features, including an amino terminal β-
barrel, now known as a PLAT (Polycystin-1, LOX, Alpha-Toxin) domain and a much larger α-
helical domain that houses the catalytic iron (Figure 4-4A). The animal enzymes are significantly 
smaller than the plant enzymes (~650 vs ~900 amino acids, respectively). The iron atom located 
at middle of the “J-shaped” active site (Figure 4-4B), is ligated with 5-6 amino acids, including 
3-4 histidine (Figure 4-5) [85]. LOXs use their iron to catalyze the following reaction [86]: 
 
Fatty acid + O2  fatty acid hydroperoxide 
 
Although free AA is the main substrate of AA, there are a few studies on oxygenation of 
esterified AA using LOXs, particularly 15-LOX. 
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Figure 4-3 Lipoxygenase phylogenetic tree.  
Representative plant and animal lipoxygenases were compiled into the phylogenetic tree using MegAlign 
(DNASTAR, Inc.) (adapted from [84]). 
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Figure 4-4 Structure of human 15-LOX-2.  
A. Structure, and B. active site containing AA, based on PDB ID: 4NRE [29]. 
 
 
Figure 4-5 A comparison of the iron coordination environments for the mammalian LOXs. 
The iron environment in 12-LOX is much closer to a six coordinate octahedral geometry than in 5- or 15-
lipoxygenase. The central spheres represent the iron atoms [85]. 
 
The overall peroxidation process is assumed to initiate from hydrogen abstraction from the –
CH2– group lying between the two –HC=CH– groups of AA by the Fe(III)–OH moiety 
(Figure 4-6) [87]. The whole process occurs throughout four steps. First, an electron goes to the 
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iron center, and a proton goes to the –OH, through a process known as proton-coupled electron 
transfer (PCET) (structure I). Second, molecular oxygen (O2) attacks the substrate (structure II). 
Third, structure II lowers the energy by transferring to structure III. Lastly, structure III is 
reduced via transfer of a H from the Fe(II)–OH2 moiety to give the final anticipated hydroperoxy 
product (structure IV) [87]:  
 
Figure 4-6 The general substrate 
peroxidation mechanism by LOXs [87]. 
  
 
 
 
 
 
 
LOXs are multi-functional enzymes to produce diversified produces. The main substrate of 
LOXs, AA, can be oxygenated not only at a major site (C-12 for 12-LOX and C-15 for 15-LOX) 
but also at alternate sites (C-15 for 12-LOX and C-12 for 15-LOX). Hence, more than one 
product can be formed using a single enzyme. Moreover, LOXs can oxygenate an AA at multiple 
sites. Furthermore, the primary hydroperoxides can be converted to epoxy [86]. 
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4.4 APPROACH 
Determining LOX charge: Protein Calculator v3.4 —an online server 
(http://protcalc.sourceforge.net) to calculate protein properties based on a sequence— was used 
to predict the total charge of 15LOX-2 at various pH’s, and to estimate its isoelectric point (IP). 
The results are provided in Table 4-1. 
 
Table 4-1 15LOX-2 molecular weight, isoelectric point and charge. 
Isotopically averaged  
molecular weight 
Estimated  
isoelectric point (PI) 
Charge at pH 
6.0 6.5 7.0 7.5 8.0 8.5 
78019.97 6.47 7.5 -0.6 -8.0 -12.9 -16.7 -21.3 
 
Sequence and structure alignment: The full-length structure of human 15LOX-2 and human 
5LOX are available in PDB database (PDB ID’s: 4NRE and 3O8Y, respectively).  However, the 
porcine leukocyte 12LOX coordinate file (PDB ID: 3RDE) contained only the C-terminal active 
site domain of the protein, but not the N-terminal membrane binding domain. Therefore, we used 
BLAST sequence alignment server [88] to compare 12LOX and 15LOX sequences. The results 
described 36% identity and 50% similarity, which convey a high level of resemblance. 
Subsequently, 3D structures of the active site of these two enzymes were compared using 
PDBeFOLD online server -protein structure comparison service PDBeFold at European 
Bioinformatics Institute [89]. Interestingly, RMSD value of 1.30 and Q-score of 0.61 represent 
that the 3D structures of porcine 12LOX and human 15LOX-2 are also closely similar. However, 
about 40% mismatch in 3D structure may represent significant variations in their functions, as 
15LOX mainly oxygenates AA at C-15, but 12LOX peroxidases its substrate predominantly at 
C-12. 
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Molecular docking: A molecular docking modeling was employed to study interactions of 
free/esterified fatty acids and known/proposed inhibitors with 5, 12 and 15LOX structures. Due 
the large size of LOXs, we applied a large grid boxes for our docking. Due different number of 
residues and enzyme’s size we used grid boxes with dimensions of 80 × 70 × 102 Å, 84 × 76 × 
78 Å and 112 × 102 × 72 Å for 5LOX, 12LOX and 15LOX respectively. Three docking 
modeling were run using three different random number generator seeds, with exhaustiveness set 
at 14 to obtain a higher accuracy to find the binding site and reduce the discrepancies among the 
obtained binding affinities. The best models were designated based on the lowest binding 
energies for lipids selective bound at the LOX active site  
CGMD simulations: CGMD simulations were applied to study the interactions of LOX with the 
membrane composed of six classes of PL. CGMD simulations provided insights regarding 
protein binding to the membranes, which explained the differences in activity of LOX towards 
the different PLs. Furthermore, the key residues during the recognition and stabilization stage of 
the interactions were identified. Analysis of the final configuration of the CGMD runs revealed 
the preferred PL substrate of 15LOX-2. 
4.5 RESULTS AND DISCUSSIONS 
In this study, using molecular modeling we examined the mechanism of LOX-dependent lipid 
signaling in ferroptosis. To this end, the binding of free and esterified fatty acids to three 
different LOXs were carefully examined to find out what are the favored substrates in this family 
of enzymes. 
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4.5.1 LOX Catalytic Mechanism and Preferred Substrates  
LOX’s are believed to play a central role as peroxidases in ferroptosis mediated cell death, that is 
driven by massive oxidation of PLs. Yet, the mechanism of PL binding to the catalytic site of 
LOX’s has never been studied. Here, for the first time, we applied molecular modeling, to study 
the mechanism of PL binding to the LOX active site, and consequently predict the preferred PL 
substrate of LOX, in an effort to identify the PL species critical for ferroptosis. Our studies were 
primarily focused on the 15LOX-2 isozyme, which is the most prevalent in ferroptosis, and its 
substrate, arachidonic acid (AA).  
4.5.1.1 Role of R429 on oxygenated products 
We initially examined the interactions of AA —an established substrate of the LOX enzyme 
family, with 15LOX-2, using rigid and flexible molecular docking. In rigid docking all the 
residues of the receptor are considered immobilized. The binding pose analysis of the rigid 
docking represented “tail-in” orientation of AA in J-shape active site of LOX (Figure 4-7A). The 
binding affinity of the top-ranked model was -7.4 kcal/mol. Henceforth, this model will be used 
as a positive control. The tail-in orientation results in preferential oxygenation of AA at C-15, 
with a lower favorability for the C-12 double bond. This binding is stabilized with many 
hydrophobic residues in the active site and charged groups located at the opening of the active 
site. For rabbit reticulocyte 15S-LOX (PDB ID: 2P0M) —a homologue of human 15LOX-2— it 
has been proposed that R403 is responsible to stabilize the carboxylic group of AA [90, 91]. 
R429 is the only positively charged residues placed in close vicinity of the active site opening in 
human 15LOX-2. Using docking, we predicted the side chain of R429 plays a similar role as 
R403 in rabbit 15LOX to form a salt bridge with COOH group of AA.  
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Figure 4-7 Molecular docking data shows R429 is stabilized the tail in orientation of the substrate in the 
active site of 15LOX-2.  
A. The tail in orientation of AA using rigid docking. B. The head in orientation of AA in flexible docking while the 
site chain of R429 moves away. C. The head in orientation of AA in R429A point mutation experiment.  
 
In flexible docking the dynamics properties are assigned to one or more selected residues. The 
data from flexible docking demonstrated that the dominant orientation of AA is “head in”, while 
the side chain of R429 mostly moved away from its crystalized location. The top-ranked model 
showed binding affinity of -7.3 kcal/mol. The “head in” orientation facilitates the oxygenation at 
C-7 or C-9. We deduced that the flexibility R429 side chain, which supposed to occur in vivo, 
may vary the oxygenated products.  
We further evaluated the role of R429 by mutating it to an uncharged amino acid, such as 
Alanine. Among the nine generated models, the head in orientation was dominant in the mutant. 
Interestingly, R429A mutation reduced the binding affinity dramatically to -6.0 kcal/mol 
highlighting the necessity of R429 to stabilize the substrate in the catalytic site. 
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4.5.1.2 Interactions of 5, 12 and 15LOX with free fatty acids 
Comparing the interactions of four free polyunsaturated fatty acids (PUFAs) with 5, 12 and 
15LOX (Figure 4-8) revealed that each LOX interacts with all four free PUFAs with almost 
similar binding affinities. A typical binding pose of free PUFAs in catalytic site of 15LOX-2 
illustrated in Figure 4-9. AA, lineolic acid (LA), eicosapentaenoic acid (EPA) and 
docosahexaenoic acid (DHA) bind to 15LOX-2 catalytic site with binding energies of -7.0 ± 0.7, 
-6.5 ± 0.1, -6.3 ± 0.3 and -7.0 ± 1.6, respectively.  
 
Figure 4-8 The binding affinities of four 
polyunsaturated fatty acids (PUFAs) with 5, 
12 and 15LOX. 
 
 
 
 
 
Among the three LOX isozymes, the binding affinities for the FA decrease in the order 15LOX > 
12LOX > 5LOX (Fig. 1-8). While the reason for the difference in affinities among isozymes 
having similar 3D structures is unclear, these data highlight a likely prominent role for 15LOX in 
ferroptotic cell death, over other LOX isozymes. 
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Figure 4-9 A typical binding pose of (A) AA, (B) LA, (C) EPA and (D) DHA to 15LOX-2. 
 
In addition to AA, which has a physiologically important substrate in ferroptosis, other FAs, 
including the longer chain “adrenic acid (AdrA)” have also been identified. The close binding 
affinities and high degrees of similarity of the binding poses of AA and AdrA suggested that they 
have equal susceptible of oxygenation via LOXs (Figure 4-10). 
 
 
Figure 4-10 AA and AdrA are equally susceptible to be peroxidized via 15LOX-2.  
Molecular docking shows the structural arrangement of 15LOX-2 active site perfectly fit to accommodate both AA 
(A) and AdrA (B) (with the binding energies of -7.0 ± 0.7 and -6.9 ± 0.4, respectively (n=3)), denoting almost equal 
susceptibility of the oxidation of these free fatty acids.  
 
A	 B	 C	 D	
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4.5.1.3 Interactions of 5, 12 and 15LOX with phospholipids 
According to the recent experimental data (unpublished), PUFA-containing phospholipids (PLs) 
are susceptible to be substrates of LOXs. Accordingly, we explored PUFA-containing PLs, 
specially those containing AA, to identify the preferred PL substrate of LOXs. 
 
 
Figure 4-11 The PLs mainly bind to 12 
and 15LOX with relative high affinities. 
PLs contain stearic acid (18:0) and 
arachidonic acids (20:4) chains bind to the 
active site of LOXs with almost similar 
binding energies. PS demonstrates low 
affinities to all three LOXs. 
 
Among all six SA-based PLs, 1-stearoyl-2-arachidonoyl-sn-glycero-3-phospho-L-serine (SAPS) 
demonstrated the lowest binding affinities toward all three LOXs (Figure 4-11). Although SAPI 
exhibited the highest binding affinities, the binding energies of SAPC, SAPG, SAPI, SAPE and 
SAPA are comparable. In case of 15LOX-2, the binding energy of SAPS is significantly lower 
than other PLs. Therefore, we conclude that SA-based PL’s are potential substrates of 15LOX-2 
except SAPS, which binds with a substantially lower binding energy comparing other PLs. Using 
molecular docking we were unable to identify the best PL substrate of 15LOX-2. The in vitro 
and in vivo data, however, demonstrated different effects for various PLs. For instance, in vitro 
experiments using liposome, 15LOX-2 and low amount of peroxidase as an activator showed 
that the preference for PL decreased in the order PA > PG > PE at 31.6%, 14.7% and 9.6% 
respectively. Consistent with modeling data, PS showed the lowest level of oxidation comparing 
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other PLs (2%) On the other hand, in vivo data revealed that PI and PE were (per)oxidized 
dramatically higher than other PLs –data from the global analysis of the ox-lipids in GPX4 
deficient cells. 
 
Figure 4-12 SA-PE and SAdr-PE are 
equally susceptible to be peroxidized 
via 15LOX-2.  
The molecular docking results 
explained that two typical PE species 
containing PUFA, including 
PE(18:0/20:4) (A) and PE(18:0/22:4) 
(B) bind to 15-LOX-2 active site with 
binding energies of -7.2 ± 0.4 and -6.8 ± 0.2 respectively (n=3) demonstrating high degrees of structural and binding 
affinities resemblance.  
 
The correlation of cell death and lipid oxidation explained that PUFA-containing PEs are 
potential signals and biomarkers of ferroptosis. Consequently, we have examined the structural 
arrangement of two key players of PE-having polyunsaturated acyl chains (18:0/20:4, and  
18:0/22:4), in the active site of 15LOX-2 using docking method. It can be seen that both species 
of PE binds analogously in the catalytic site with highly similar binding affinities (Figure 4-12). 
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4.5.2 Interactions of 15-LOX-2 and a ER-membrane Mimic 
Next, we utilized CGMD simulations (two trails for 2 μs) to carefully examine the interactions of 
15LOX-2 with membrane. Based on the fluorescence microscopy data, ER is actively involved 
in ferroptotic cell death. Accordingly, we used a lipid composition approximately mimicking the 
ER-membrane (Table 4-2) [92].  
 
Figure 4-13 CGMD simulations of the interactions of 15LOX-2 with a ER-membrane mimic.  
A and B. CGMD1 and CGMD2; i. 15LOX-2 interacting with the membrane with its amino-terminal β-barrel domain 
called PLAT (polycystin-1-lipoxygenase α-toxin) domain (blue); ii. the helical active site was removed (for clarity) 
to compare the orientation of the PLAT domain on the membrane; iii. whole protein was removed to illustrate the 
interacting lipids with PLAT domain. Representation guide: yellow: three species of PC (DPPC, pOLPC and 
SAPC); orange: SAPI; cyan: two species of PE (SAPE and pSAPE); green: two species (SOPS and SAPS); blue: 
PLAT domain; red: α-helical catalytic domain. 
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CGMD data confirmed that the amino-terminal β-barrel domain called PLAT (polycystin-1-
lipoxygenase α-toxin) domain of 15LOX-2 is responsible for membrane binding (Figure 4-13A 
& B). Although in both runs the PLAT domain was oriented analogously in the membrane, the 
alignment of the helical active site was slightly varied.  
 
 
Figure 4-14 The reconstructed predicted orientation of 15LOX-2 in the membrane  —based upon CGMD 
simulations— to identify the location of the catalytic site opening versus surface of the membrane. 
Cartoon representation colored in spectra from blue to red denoting N- to C-terminal. Red and green spheres 
representing iron and calcium. The zoomed in panel shows that the active site opening is located on top of the 
membrane surface. 
 
It should be noted that 15LOX-2 deeply penetrates in the membrane. The analysis of the 
interacting lipid represented that the PLAT domain even interacts with lipids on the opposite 
leaflet. The PLAT interacts with five and three lipids in CGMD1 and CGMD, respectively. In 
CGMD1 the PLAT domain interacts with two PC (16:0/16:0), one pPC (18:1/18:2), one PI 
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(18:0/20:4) and one PE (18:0/20:4). In CGMD2, however, only two PC (16:0/16:0) and one PE 
(18:0/20:4) were involved in the interactions with the PLAT domain. 
To establish the positioning of the catalytic site opening and its orientation versus the 
membrane surface, we reconstructed the enzyme orientation in the membrane based on CGMD 
data. The surface and cartoon representations of 15LOX-2 were merged and oriented similar to 
CGMD2 binding configuration. The magnified J-shaped catalytic site (using the cavity 
representation of PyMol software) exhibited the approximate arrangement of the opening against 
the membrane surface (Figure 4-14).  
A loop at the interface of the PLAT domain and helical active site in the crystal structure 
of 15LOX-2 (residues 120 to 132, EGTAKVSWADHH) acts as a hinge providing some degrees 
of flexibilities for helical domain while the PLAT domain is firmly bound in the membrane. 
Therefore, the position of the catalytic site opening varies due to the movement of whole helical 
domain. This motional feature can be connected to the activation mechanism of LOX’s, which 
needs further investigations. 
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Figure 4-15 The hydrophobic analysis of the PLAT domain of 15LOX-2. 
The residues around 80 present the longest coil in 15LOX-2, which should be responsible in initiating hydrophobic 
interactions with membrane hydrophobic core.  
 
Table 4-2 The analysis of interacting lipids with NMBD of 15LOX-2. 
Lipids present in 
the bilayer 
Total 
number of 
lipids in 
each leaflet 
Percentage 
of lipids in 
each leaflet 
Number of 
lipids 
interacting 
with LOX 
(CGMD1) 
Percentage of 
the interacting 
lipids 
(CGMD1) 
Number of 
lipids 
interacting 
with LOX 
(CGMD2) 
Percentage of 
the interacting 
lipids 
(CGMD2) 
PC (16:0/16:0) 160 40.0 1 0.6 6 3.8 
pPC (18:1/18:2) 40 10.0 0 0.0 0 0.0 
PC (18:0/20:4) 20 5.0 2 10.0 0 0.0 
PI (18:0/20:4) 28 7.0 2 7.1 2 7.1 
PE (18:0/20:4) 80 20.0 0 0.0 3 3.8 
pPE (18:0/20:4) 40 10.0 2 5.0 4 10.0 
PS (18:0/18:1) 28 7.0 0 0.0 0 0.0 
PS (18:0/20:4) 4 1.0 0 0.0 0 0.0 
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Figure 4-16 SAPI is the only PUFA-containing phospholipid in 15Å distance of the catalytic site of 15LOX-2.  
The side view of the final configurations of CGMD1 and CGMD2 representing the only PL is in 15Å distance of the 
opening of the catalytic site of 15LOX-2. The distance was measured from the location of R429 residue, which is 
located at the entrance of the J-shape active site. Representation guide: yellow: three species of PC (DPPC, pOLPC 
and SAPC); orange: SAPI; cyan: two species of PE (SAPE and pSAPE); green: two species (SOPS and SAPS); 
blue: PLAT domain; transparent red: α-helical catalytic domain; purple: R429. 
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To discover the binding domain recognizing the hydrophobic core of the membrane, we 
calculated the hydrophobic indices of PLAT domain residues (Figure 4-15). The data suggested 
that β-hairpin structure consisting highly hydrophobic amino acids around residue 80 are the 
membrane recognition domain, in line with a study was done by Kobe et al [29]. 
Next, we analyzed the interacting lipids involved in binding. In CGMD1, the lipids 
interacting in order of PC > PI > PE, and in CGMD in order of PE > PI > PC. To considering the 
concentration of the lipids in the membrane, the percentage was calculated based on the original 
number of lipids in the membrane. The discrepancy in the data suggested that lack of specificity 
of lipids to interact with PLAT domain (Table 4-2). 
We further searched for the lipids around the active site, while no direct interactions with 
the membrane were observed. In both CGMD runs, only SAPI is located close the active site 
opening, which suggest feasibility of PI lipids to be oxidized via lipoxygenases (Figure 4-16). 
The measurements were performed based on the position of R429 residue located at the close 
proximity of the active site opening. 
4.5.3 Can Inhibitors of Ferroptosis Potentially Inhibit LOXs? 
The LOX inhibitors can be categorized into 5 groups; (i) redox inhibitors interfering with the 
valency change of iron during the catalytic cycle, (ii) iron chelators making complex with iron 
ion at the active site, (iii) compounds binds to active site competing with substrate AA binding, 
(iv) suicide substrates leading to inactivate the enzyme and (v) allosteric inhibitors. Here, we 
evaluated several known and proposed inhibitors of LOX family enzymes, particularly 15LOX 
(or 12/15LOX) inhibitors. We mainly tested the inhibitors that have been reported to block 
ferroptotic  cell death [25] to test our hypothesis that “the LOXs inhibition impede ferroptosis 
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cell death”. Baicalein, a known inhibitor of 15LOX —not tested for ferroptosis— was used as a 
positive control. We next explored the inhibition mechanism of LOXs using vitamin Es. Firstly, 
the chemical properties and structures of inhibitors will be introduced. Secondly, their structural 
arrangements in the catalytic site of 15LOX-2 and their binding affinities will be reported.  
4.5.3.1 Structures of ferroptosis/LOXs inhibitors  
Zileuton (trade name ZYFLO) (Figure 4-17A) is an active inhibitor of 5LOX enzyme, and thus 
inhibits leukotrienes (LTB4, LTC4, LTD4, and LTE4) formation. Zileuton is used for treatment 
of asthma [93]. It is a tested inhibitor of ferroptosis showing a strong effect to hinder ferroptotic 
cell death. 
PD 146176 (Figure 4-17B) is a potent inhibitor of reticulocyte 15-LOX-1. It an anti-oxidant 
agent for stress-induced apoptosis in endothelial cells. In addition, it lacks significant non-
specific antioxidant properties [94]. It is a tested inhibitor of ferroptosis demonstrating a strong 
effect to hamper ferroptosis with low doses; however, cell viability decreased significantly using 
higher doses. 
Baicalein (5,6,7-trihydroxyflavone) (Figure 4-17C) is a flavone, originally extracted from the 
roots of Scutellaria baicalensis and Scutellaria lateriflora. In addition of inhibition of 12/15LOX 
[95], it has been shown baicalein acts as an anti-inflammatory agent as well [96]. It is known for 
its antioxidant properties. Baicalein also has never been examined to inhibit ferroptosis. We have 
employed this compound as a known inhibitor of 15LOX to compare binding energies of other 
inhibitors. 
MK-866 (Figure 4-17D) is an inhibitor 5LOX involved in leukotriene biosynthesis (IC50 = 3 nM 
in human polymorphonuclear leukocytes). MK866 inhibits 5-LOX-activating protein (FLAP). It 
blocks and reverses the membrane association of 5-LOX [97]. Conversely, MK 866 induces 
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apoptosis through the mitochondria-dependent pathway [98]. MK-866 also is an examined 
ferroptosis inhibitor, which does not revealed a strong inhibition even in high doses. 
 
 
Figure 4-17 The structures of ferroptosis/LOXs inhibitors.  
Ferrostatin-1, Liproxstatin-1 and SRS 16-86 are the specific inhibitors of ferroptosis. 
 
Necrostatin-1 (Nec1) (Figure 4-17H) is an inhibitor of RIP1 kinase that blocks the death of 
TNF-α-treated FADD-deficient cells with an EC50 value of 490 nM. It is exclusively known as 
an inhibitor of necroptosis. Nec1 also plays a role to rescue Gpx4 deficient cells.  
Ferrostatin-1 (Fer1) (Figure 4-17F) has been introduced as a ferroptosis inhibitor in 2014, 
simultaneously when this cell death pathway was discovered [76]. Later, Lirpoxtatin-1 
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(Figure 4-17G) [25] and SRS 16-86 (Figure 4-17E) [99] were introduced to block the cell death 
induced by Gpx4 loss. SRS 16-86 is also called third-generation ferrostatin. It is more stable, to 
metabolism and plasma, and more potent, compared with Fer-1. 
4.5.3.2 The binding affinities of ferroptosis/LOXs inhibitors to 15LOX-2 
Figure 4-18 demonstrates the binding energies of the tested ferroptosis inhibitors comparing to 
baicalein —the known inhibitor of 12/15LOX. All the compounds bound at the opening of the 
catalytic channel. The visual inspection of the biding poses all the tested inhibitors suggested 
“corking” inhibition mechanism to block the J-shape catalytic site. However, other inhibition 
mechanism, such as iron chelation may be involved, which cannot be addressed using the rigid 
and simplified molecular docking. 
Interestingly, the last two proposed inhibitors of ferroptosis bound 20 15LOX-2 active 
site with high affinities —significantly higher than AA. The modeling data and available 
experimental data again highlighted the potential role of 15LOX-2 in ferroptosis cell death 
pathway. Since Friedmann et al [25] clearly stated that no individual lipoxygenase can be solely 
responsible for the cell death processes downstream of GPX4 inactivation, we examined the 
binding of these compounds to 5 and 12LOX as well (data not shown). All compounds bound to 
5 and 12LOX with significantly higher binding energies (lower affinities) compared to 15LOX. 
Overall, all the substrates and inhibitors binds stronger with 15LOX, possibly indicating the 
critical role of 15LOX in ferroptosis pathway —in agreement with the available experimental 
data. 
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Figure 4-18 The binding affinities of ferroptosis/LOXs inhibitors to human 15LOX-2.  
 
4.5.4 Tocotrienols Are More Effective Inhibitors of Ferroptosis Comparing Tocopherols 
Friedmann et al [25] and recent findings in our group confirmed that vitamin E family, 
tocopherols (Tp’s) and tocotrienols (Tt’s) are the equipotent inhibitors of the cell death induced 
by GPX4 inactivation. Khanna et al [100] studied the role of α-Tp on the 12LOX activity and 
proposed α-Tp may hamper the access of AA to the catalytic site of 12LOX by binding to the 
opening of the solvent cavity adjacent to the active site. In addition, several studies explained 
that vitamin Es can inhibit 15LOX (12/15LOX) and 5LOX [101, 102]. Yet, the mechanism of 
action of this molecule on LOXs remained to be elucidated. Here, we explored the different 
members of vitamin E family —eight isoforms in total— to study their potential mechanism of 
action using molecular modeling. 
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All the vitamin E isoforms have a chromanol ring and a 16-carbon phytyl-like side chain, 
in which Tp’s are saturated and Tt’s have three double bonds (Figure 4-19). Different isoforms 
of Tp’s and Tt’s vary at the 5- or 7-position of the chromanol ring with either an H or a CH3 
group. 
 
 
Figure 4-19 Structures of tocopherols (Tp’s) and tocotrienols (Tt’s). 
 
Molecular docking represented that the binding energies of all Tt’s isoforms of vitamin E are 
lower —defining the higher affinity— comparing to corresponding isoforms of Tp’s 
(Figure 4-20). Yet, the biding energies of α-, β-, γ- and δ-tocopherols are comparable. This trend 
was observed for Tt’s isoforms as well. 
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Figure 4-20 Molecular docking represent that the binding energies of all tocotrienol isoforms of vitamin E are 
lower —defining the higher affinity— comparing to corresponding isoforms of tocopherol (n=3).  
 
 
Figure 4-21 Tocopherols and tocotrienols are equipotent inhibitors of 15LOX-2. 
(A) Typical binding poses of tocopherol (i) alpha, (ii) beta, (iii) gamma and (iv) delta. (B) Typical binding poses of 
tocotrienol (i) alpha, (ii) beta, (iii) gamma and (iv) delta. 
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Moreover, the comparison of Tp’s and Tt’s binding at the catalytic site clearly represent these 
molecules —in different ways— blocks the substrate binding site Figure 4-21. Although vitamin 
E’s are known for their radical scavenging properties, the modeling data suggested  a corking 
mechanism. The corking molecule competes with the LOX’s substrate to prevent the 
oxygenation process. 
4.5.5 Comparison with Experimental Results 
Through modeling it is possible to predict the binding affinities of different FFAs and PLs with 
the three LOX’s under study, including 15LOX, 12LOX and 5LOX. The modeling data showed 
that FFA and PL have the highest affinity to bind to 15LOX. This finding is in line with 
published experimental data highlighting the role of 15LOX compared to other LOX’s in 
ferroptosis pathway by knocking down LOX’s one by one [81]. 
Furthermore, my study of the interactions of eight isoforms of vitamin E, including 
tocopherols and tocotrienols, with LOX’s revealed that tocotrienols have higher affinities to 
interact with LOX’s. These data are in concert with the experimental data based on cell viability 
of GPX4 deficient cells treated with vitamin Es that showed high potency of tocotrienol to 
inhibit ferroptosis (manuscript is under preparation). It should be noted that LOX’s play a key 
role in lipid peroxidation in this cell death pathway. 
Finally, the membrane binding behavior of the 15LOX confirmed the involvement of the 
N-terminal domain (called PLAT) in the membrane binding, in line with previous studies [29]. 
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4.5.6 Discussion and Conclusion 
Ferroptosis is a newly coined term for one of the programmed death pathways that emphasizes 
the mechanism of cell demise associated with the dysregulation of thiol and lipid oxidative 
metabolism controlled by GPX4 [81, 82]. Execution of apoptosis includes oxidation of CLs as a 
required step in apoptosis. In contrast, CL oxidation was not involved in ferroptotic signaling 
(unpublished results). On the other hand, the redox signaling in ferroptosis is dependent on 
specific engagement of PE (unpublished experimental data). This also includes different acyl 
molecular speciation whereby LA(18:2)-containing oxygenated CLs are utilized in apoptosis and 
oxygenated AA- and AdrA-PE species —in ferroptosis. Moreover, the oxygenating enzymatic 
mechanisms of apoptosis and ferroptosis are also different viz., cytochrome c [103] and 15LOX, 
respectively.  
It has been shown that the accumulation of PE-OOH is confined to the extra-
mitochondrial ER-associated compartments where several iron proteins —COX, LOX and 
CYP450— can generate PUFA hydroperoxy-intermediates as the primary molecular products of 
their reactions (according to the available live cell imaging data). Of those, only LOX’, utilize di-
acyl lipids as their substrates, thus making these non-heme-iron enzymes the prime candidate-
catalysts and sources of ferroptotic oxygenated PE-species.  
Our goals here, were to understand the mechanism of LOX-driven lipid signaling. 
Molecular modeling showed the substrate arrangement in the catalytic site of 15LOX can be tail 
in or head in (with lower probability), which suggests more than one oxygenated products for a 
particular LOX. It should be noted AA, AdaA and DHA demonstrated similar binding poses and 
binding energies to 15LOX-2 (~ -7.0 kcal/mol). Yet, the bio-availability and accessibility of the 
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substrate can also affect the kinetics, an aspect that  cannot be addressed using molecular 
modeling.  
We also explored the probability of the oxygenation of PLs via 5, 12 and 15LOX, using 
computational methods. Our data proposed —five out of six— classes of SA-based PLs can 
effectively interact with the active site of LOXs. Only SA-PS demonstrated significantly low 
affinities toward all three LOX’s, comparing others. Following the experimental data, we tested 
two main lipid biomarkers of ferroptosis, SA-PE and SAdrA-PE. Selectivity of LOX towards PE 
species was not confirmed using modeling data. Indeed, the traditional mechanism of LOX 
catalyzed oxygenation of free PUFA is based on the selectivity of the respective PLA2 in 
releasing the substrates of LOX reaction. In case of esterified substrates, the question —how 
would LOX identify PUFA-PE species, among many other phospholipids with AA- and AdrA-
residues for the selective peroxidation? The mechanism based on the formation of specific PE-
LOX complexes is not compatible with our computer modeling data indicating that diversified 
(phospho)lipid classes can effectively interact with LOX. One possible mechanism is a non-
bilayer organization of PE in membranes that facilitates availability of these substrates for the 
enzymatic attack.  
To decipher the membrane binding mechanism of 15LOX-2, we ran long CGMD 
simulations and proved it bound with the similar orientation for the PLAT domain, but quite 
different for helical active site. These results can be ascribed to the presence of a coil-like 
structure functioning as hinge and provide flexibility for the active site. This flexibility can 
change the accessibility of the active site opening to the substrate. This can affect the activation 
mechanism of LOXs, which needs further evaluations. Additionally, we found that a long loop in 
the PLAT domain with the highest degree of hydrophobicity is responsible for membrane 
  84 
binding —in line with previous studies. The discrepancy in the interacting lipids with the PLAT 
domain suggested lack of lipid specificity for these interactions. The active site, however, in both 
simulations, was located to SAPI lipids representing a higher probability of using as a substrate 
by lipoxygenase enzymes. 
The inhibition mechanisms of LOXs, particularly 15LOX, were examined using the 
known inhibitor, bacalein (as a positive control), and tested/specific inhibitors of ferroptosis cell 
death. In addition of the aforementioned group of the small molecules, vitamin Es —eight 
isoforms— also were inspected to possibly explain their mechanism of action on LOX —and 
indirectly on ferroptosis. Interestingly, all the tested compounds in this study bound to the active 
site of LOXs. The specific ferroptosis inhibitors, including Fer1, liproxstatin and SRS16-86 
bound with high affinities to the active site. Among them, SRS16-86 demonstrated the highest 
affinity, more than one unit higher than baclein and AA —the known inhibitor and substrate of 
15LOX.  
Moreover, we established that different forms of vitamin Es are universally bound to the 
LOX catalytic site. Thus one of the physiologically significant mechanisms of vitamin Es action 
may be stereospecific liganding of the LOX catalytic site outcompeting the oxygenation of free 
or esterified PUFA hence regulating ferroptosis. Because different vitamin E homologues are 
effective in inhibiting essentially all LOX isoforms —this suggest, for the first time, the rationale 
for the previously reported equivocal results on the failure of the approaches based on KO 
individual LOXs to suppress ferroptosis [81]. 
Overall, our data revealed the dominant mechanism of peroxidation of esterified fatty acid 
via LOX’s and provided a possible mechanism of inhibition of LOX, particularly by vitamin E’s. 
Moreover, the membrane binding properties of LOXs were also studied.  
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5.0 CHAPTER 5: COMPUTATIONAL STUDIES OF CARDIOLIPIN 
SIGNALING IN APOPTOSIS AND MITOPHAGY 
5.1 SUMMARY 
Due to CL migration during apoptosis the inherent asymmetric distribution of CL is disturbed. It 
presumably leads to increased CL concentration on the outer leaflet of the inner mitochondrial 
membrane (IMM) and both leaflets of outer mitochondrial membrane (OMM). CL translocation 
introduces many challenging biophysical questions regarding to interactions of CL-containing 
membrane with diversified proteins/enzymes. Here, we sought the mechanism of cardiolipin 
(CL)-signaling in apoptosis and mitophagy pathways. To this end, we initially appreciated the 
physical properties and functional roles of cardiolipin in membranes utilizing molecular 
dynamics simulations. The modeling results were validated using available low-angle X-ray 
scattering (LAXS) and differential scanning calorimetry (DSC) data.  
Coarse-grained molecular dynamics (CGMD) simulations demonstrated that CL thickens 
the membrane and increases the average lipid area per head group. No significant CL clustering 
and membrane curvature were observed in symmetrically concentrated-CL-containing 
membrane. Then, we investigated the molecular details of CL interactions with cytochrome c 
(cyt-c) and LC3 to decipher the mechanism of CL signaling in apoptosis and autophagy, 
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respectively. A combination of several molecular modeling methods was employed to identify 
the CL-binding sites of LC3 and cyt-c. Moreover, the effect of protein interactions on the 
membrane properties —e.g. lipid clustering and curvature formation— was studied. In apoptosis, 
we were anxious to explain how CL/cyt-c complex formation leads to lipid peroxidation. The 
presence of two binding sites on distal and proximal sides of heme paved the path toward the 
understanding of the heme crevice opening for the substrate.  
5.2 SIGNIFICANCE 
Among the various types of lipids that form mitochondrial membranes, CL is a mitochondria-
specific phospholipid (PL) with two phosphatidyl groups linked to a glycerol backbone and four 
fatty acyl chains. The synthesis of CL is on the matrix side of IMM [104], which introduces a CL 
asymmetry. The CL asymmetry allows to membrane potential for the “healthy” mitochondrion to 
be maintained [27]. CL asymmetry is disrupted through a process called “CL externalization” 
[21]. Upon mitochondrial injury and depolarization, a significant portion of CL becomes exposed 
on the mitochondrial surface, where it serves as either the pro-apoptotic or pro-mitophagic 
signal, depending on the extent of mitochondrial injury [105]. The presence of a myriad of 
proteins associated with either the IMM or the OMM allows critical biophysical questions 
regarding the interactions of CL-containing membrane and proteins to be addressed. While many 
studies of molecular interactions of CL with proteins have been done, the common features of 
the CL-binding sites are enigmatic. Therefore, using computational approaches we examined (i) 
the structural role of CL in the membrane, (ii) the mechanism of interactions of the externalized 
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CL with cyt-c and LC3, and (iii) the consequence of protein interactions for the membrane 
properties. 
5.3 INTRODUCTION 
CL (1,3-bis(sn-3′-phosphatidyl)-sn-glycerol) is essential for the structural organization and 
function of mitochondrial membranes by supporting membrane dynamics and stabilizing the 
lateral organization of protein-rich membranes [106]. CL is an unusual anionic phospholipid 
with two negatively charged phosphate groups in its polar head and a bulky hydrophobic “body” 
containing 4-acyl chains [107, 108]. The specific features of CL result in a small head group, 
which in turn promotes negative curvature, cohesive effects between hydrocarbon chains, and 
electrostatic interactions [14]. Figure 5-1 
represent three different CL species from the 
diversified class of CLs. TLCL is an oxidizable 
CL species due to presence of two unsaturated 
bonds in each acyl chain.  
 
 
Figure 5-1 Cardiolipin is a diversified class of lipids. 
Tetramyristoyl-CL (TMCL), tetraoleyl-CL (TOCL) and 
tetralinoyl-CL (TLCL) are the CL species have been sued in this study. The latter is an oxidizable CL species.  
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Cardiolipin (CL) displays extraordinary specificity in its cellular distribution. It is found almost 
exclusively in the IMM of eukaryotes, where it constitutes about 20 % of total phospholipids 
(PLs). A stronger enrichment is found in the matrix-facing leaflet of IMM, which contains 70-80 
% CL. This has been determined using CL-specific antibodies on mitoplasts [109, 110]. The 
appearance of CL in the OMM is to be interpreted as an “eat me” signal to induce mitophagy —
the selective degradation of mitochondria by autophagy. CL externalization serves as a signal 
recognized by LC3, —an autophagosome-associated enzyme responsible for cargo recognition— 
and leads to the engagement of the autophagy machinery [28]. How the obstacles of 
transmigration from the inner leaflet of the IMM to the outer leaflet of the OMM are overcome 
has been the focus of many recent studies and several candidate enzymes have been suggested to 
be involved [26]. While mitophagy was achieved through presence of CL in its native structure 
on mitochondrial surface, modified CL species may play even more diverse roles in terms of cell 
signaling. Owing to its high unsaturation level and versatile molecular structure, lipid 
peroxidation initiated by reactive oxygen species (ROS) generates a wide range of oxygenated 
species. A physiological catalyst found responsible for CL peroxidation is cyt-c, which is linked 
to the intrinsic apoptosis cell death pathway [111]. In mitochondrial apoptosis, interactions of CL 
with cyt-c result in formation of peroxidase complexes, leading to the accumulation of oxidized 
CL (oxCL) products. This leads to the release of pro-apoptotic factors, including cyt-c, from 
mitochondria into the cytosol (Figure 5-2).  
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Figure 5-2: The illustration of CL-driven intracellular signaling pathways in mitophagy and apoptosis. 
 
Either in mitophagy or apoptosis the molecular details of the interactions of CL and target 
proteins are not fully understood. On the other hand the effect of these interactions on the 
membrane also needs to be elucidated. In this chapter we utilize a combination of several 
computational approaches to study the interactions of CL and cyt-c and LC3, involved in 
apoptosis and mitophagy, respectively. 
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5.4 APPROACH 
5.4.1 Effects of CL on the Structure and Properties of Lipid Membranes 
To shed light on the molecular details of lipid signaling through maintaining/disrupting CL 
asymmetry, one should initially appreciate the effects of CL on the structure and properties of 
lipid membranes.  
The CGMD simulations of lipid bilayer systems were carried out with the MARTINI 
force field. Two CL species were used, including tertramyristoyl-cardiolipin (TMCL) and 
tertraoleoyl-cardiolipin (TOCL). Six different lipid bilayer systems, including pure DMPC, pure 
DOPC, DMPC containing 20% TMCL, DOPC containing 5, 7.5, 10 and 20% TOCL were 
studied. Na+ ion was added to each simulation box to neutralize the total charges. Initially, each 
system was minimized, and a 20 ns NVT (constant number of particles, volume and temperature) 
ensemble equilibration was followed by a 20 ns NPT (constant number of particles, pressure and 
temperature) ensemble equilibration. Each MD run was carried out to cover 500ns. A 40fs time 
step was used to integrate the equations of motion. For all simulations, analyses were performed 
using the last frame in the 500 ns trajectory for the snapshots. Number densities were determined 
using the undulation correction method with filter cutoff q0 = 1.0 nm
−1 [112, 113]. Areas were 
calculated by dividing the size of the simulation box (XY) by half the number of lipids. Finally, 
the membrane properties calculated via simulations compared with available experimental data 
obtained from differential scanning calorimetry and SXray. 
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5.4.2 Study Interactions of CL and Cyt-c 
Molecular Docking: The structure of the TOCL was docked to the crystal structure of native cyt-
c (pdbid: 1HRC) [114]. Three docking modeling sessions were run using three different random 
number generator seeds. A cubic box was positioned at x, y, and z values of 46.839, 23.029, and 
5.505, respectively. The center was built around the protein with 52 × 52 × 52 points and a 
spacing of 0.375 Å between the grid points. The top 9 resulting orientations were clustered 
together based upon the RMSD value with respect to model 1. The best ligand bound receptor 
structure in each case was chosen based on lowest energy, visual inspection (to recognize 
similarities of the models), as well as the total number of conformations in a cluster. 
Orientations of Proteins in Membranes (OPM): Protein orientation on the membrane was 
predicted using OPM server applying default settings [115].  OPM offers spatial arrangements of 
proteins with respect to the hydrophobic core of the lipid bilayer. The rotational and translational 
positions of peripheral and trans-membrane proteins in membranes can be calculated using this 
online server. OPM only requires the 3D structure of the interested protein (PDB coordinate file) 
as input.  
The CGMD simulations: 400 lipids, including 1,2-dioleoyl-sn-glycero-3-phosphocholine 
(DOPC) and TOCL, were used to construct the membrane. Five membranes with varying TOCL 
amount of 0 (control), 5, 7.5, 10, and 20 mol% TOCL were chosen and subjected to simulation. 
The composition of the lipids in each membrane listed in Table 5-1.  
The CG model of DOPC and TOCL molecules is illustrated in Figure 5-3. Each system 
equilibrated with three different random seeds to produce different initial velocities and thus 
different trajectories. In total, 15 simulations were run, 1 microseconds each. Initially, each 
system was minimized for 20 ps, before 1 ns NVT and 1 ns NPT ensemble equilibration. The 
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position of protein was restricted during equilibration runs. A 15 fs time step was used to 
integrate the equations of motion. 
 
Table 5-1 The composition of the membrane used for CGMD simulations of CL/cyt-c interactions. 
CL concentration in 
the membrane 
(mol%) 
Number of 
DOPC 
Number of 
TOCL 
0 (Control system) 400 0 
5 380 20 
7.5 370 30 
10 360 40 
20 320 80 
 
 
 
 
  
Figure 5-3 CG model of DOPC (left) and TOCL (right) molecules based on the MARTINI force field. 
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5.5 RESULTS AND DISCUSSIONS 
5.5.1 Physical properties and functional roles of cardiolipin in membranes 
CL-containing membranes, in general, are vulnerable to forming negative curvature and 
thickening, and depending on the CL species, it may rigidify or liquefy the membrane. CGMD 
simulations based on MARTINI force field, in line with differential scanning calorimetry (DSC) 
and SXray, suggest that TMCL does not form domains within the DMPC bilayers (Figure 5-4 A) 
[116].  
 
Figure 5-4 TMCL induces thickening and increasing the area per lipid head group in mixture with DMPC.  
A. interactions of TMCLs and DMPCs in bilayer thicken and stiffen the membrane, B. Number densities calculated 
from the CGMD Martini simulation of (a) DMPC and (b) DMPC/20mol% TMCL. Color code: water (black), 
DMPC phosphocholine (red), DMPC glycerol-carbonyl (green), TMCL phosphoglycerol (cyan), TMCL glycerol-
carbonyl (magenta), DMPC chains (blue) and TMCL chains (dark yellow). 
 
  94 
The number densities calculated from CGMD simulation, in concert with experimental results, 
demonstrated that the presence of 20 mol% tetramyristoyl-CL (TMCL) induces a thickening of 2 
Å and an increase in the area per lipid head group of 8 Å2 in a mixture with 1,2-dimyristoyl-sn-
glycero-3-phosphocholine (DMPC) (Figure 5-4 B). Interestingly, the data revealed that the 
TMCL headgroups localize near the glycerol-carbonyl region of DMPC; i.e., they are 
sequestered below the DMPC phosphocholine headgroup (Figure 5-4 B). 
 
 
Figure 5-5 TOCL thickens the membrane and increases the average lipid area per head group in presence of 
DOPC as a matrix lipid in the bilayer. 
 
We have re-evaluated our finding using another species of CL, 1,1′,2,2′-tetraoleoyl-cardiolipin 
(TOCL), in the membrane with a different concentration of TOCL. In sum, regardless of lipid 
species, the presence of CL in the bilayer thickens the membrane and increases the average lipid 
area per head group in the presence of DOPC as a matrix lipid in the bilayer (Figure 5-5). 
Additionally, no significant CL clustering (domain formation) or membrane curvature was 
observed. 
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5.5.2 Computational Studies of CL-signaling in apoptosis 
Cyt-c is an inter-membrane space (IMS) mitochondrial protein, which carries electrons from the 
inner mitochondrial membrane (IMM) proteins respiratory complex III (cytochrome c reductase) 
to complex IV (cytochrome c oxidase) [111, 117, 118]. Cyt-c is a highly conserved, alpha helical 
globular protein, composed of 104 amino acids [119]. The prosthetic heme group of cyt-c is 
covalently linked to the peptide chain at positions Cys14 and Cys17 [120] (Figure 5-6 A). The 
heme iron is in hexa-coordinated form, with four covalent bonds from the porphyrin’s nitrogen 
atoms and two axial ligands, His18 and Met80 [114, 121]. Upon binding to Complex III, Met80 
moves away from the covalently bonded iron to facilitate reduction [117, 122]. Cyt-c is a 
positively charged enzyme with a net positive charge of +9.2-9.6 (Figure 5-6 B), and has an 
affinity toward anionic lipids. 
In addition to the well-established bio-energetic function, cyt-c has been identified as an 
essential pro-apoptotic factor acting as a switch in mitochondria-mediated cell death pathways 
upon its release into the cytosol [107, 111, 117, 122-125]. Recent studies revealed that the 
liberation of cyt-c is mediated by its binding to a mitochondria-specific phospholipid, CL. The 
presence of CL is important for the proper structural arrangements and functioning of a number 
of proteins [126, 127]. Among those are the cyt-c-related respiratory complexes III, IV, and V 
which require two, two, and four CL molecules, correspondingly, as binding partners to maintain 
their functions [128-130].  
Under physiological conditions, only a minor fraction of CL interacts with cyt-c resulting 
in the attachment of ~10-15% of cyt-c to the IMM [125, 131, 132].  However, during apoptosis, 
trans-membrane migration of CL from the IMM to the OMM facilitates the formation of cyt-
c/CL complexes, which initiated a new peroxidase enzymatic activity [121, 126, 133]. While 
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soluble cyt-c displays only very weak peroxidase activity, it increases over 50-fold in the 
complex, as measured in the presence of H2O2 [125].  
 
 
Figure 5-6 Cyt-c structure is a Heme containing protein localized in IMS.  
A. Heme contains Fe2+ in the center, and ligated with four bonds in porphyrin ring and His18 (on proximal side) and 
Met80 (on distal side) (from http://chemwiki.ucdavis.edu). B. Cyt-c is a positively charged protein with a net charge 
~+10 in physiological condition. Blue and red spheres represent α-carbons of the positive and negative residues, 
respectively. C. Previously introduced CL binding sites of cyt-c.   
 
The gain of enzymatic activity is even up to 1,000-fold with fatty acid hydroperoxides as sources 
of oxidizing equivalents [125, 126]. The newly emerged peroxidase activity is highly selective 
towards polyunsaturated species of bound CL yielding a variety of oxygenated CL species 
(oxCL) [103]. Accumulation of oxCL leads to a permeabilization of the OMM – through yet to 
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be established mechanisms – thus facilitating the release of cyt-c into the cytosol [103, 121].  
These mitochondrial events designate the point of no return in apoptosis [103, 134] initiated by 
the binding of cyt-c to the WD-40 portion of apaf-1 in apoptosomes [103]. 
The gain of peroxidase activity requires a non-native conformation of cyt-c. Circular 
dichroism [135, 136] and electron paramagentic resonance [118, 131] spectroscopic studies 
suggest that binding of CL induces a conformational changes in the tertiary structure and partial 
unfolding of cyt-c, resulting in the reduction of its α-helical content [137-139]. Furthermore, 
changes in heme iron coordination state and redox potential have been documented [140-142]. 
The location of the binding sites for CL on cyt-c is controversial and three binding sites, referred 
to as A, C and L (Figure 5-6 C) have been proposed. An unusual number of positively charged 
residues are found in these sites and are believed to be involved in electrostatic attraction of CL 
phosphates. In particular, Lys72 and Lys73 [131, 132, 143] and Lys86 and Lys87 [144] in site A 
have been implicated in initiating complex formation, while high affinity binding may require 
additional interactions with Site C, especially Asn52 [132, 136]. At a lower pH, Lys22, Lys25, 
and Lys27 in site L have been proposed to become available for interaction [145]. Because sites 
A and L are not contiguous on the surface of cyt-c, it was proposed that binding of liposomes to 
these sites may mediate membrane fusion [132].  
Other models suggest that electrostatic interaction of cyt-c with anionic phospholipid 
membranes results in partial insertion of cyt-c into the bilayer membrane [146-148]. Finally, 
there are also extended lipid anchorage models, in which one or two of the CL’s acyl chains 
protrudes out of the membrane and inserts into a hydrophobic cavity of the protein [136, 143, 
149]. The models differ in location and nature of the hydrophobic pocket [136, 143, 149]. All 
models involve the Met80 loop, but either also involves residues 67-71 [149, 150], or 81-85, or 
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Asn52 [143]. A recent model proposes two - rather than one – of the CL acyl chains to be 
inserted into cyt-c [136].  
 
 
Figure 5-7 Molecular docking predicts three CL-binding sites, which can be generalized in two main sites 
called “distal” and proximal” sites.  
Molecular docking predicted three CL-binding sites: A. site one is located in vicinity of proximal His18, B. site two 
is placed in neighboring of distal Met80, and C. Site three represents some overlaps with site one and remaining of 
this site is extended toward the opposite side of HEME crevice opening. 
 
The diversity and often mutually exclusive character of existing models highlights the 
incompleteness of our knowledge and the complexity of the interactions between cyt-c and CL. 
Furthermore, experimental observations such as the need for a threshold concentration of CL 
required to induce peroxidase activity cannot be explained by any of these models. Therefore, we 
employed a combination of several computational approaches —validated by solution NMR data 
generated in our laboratory— to elucidate the molecular details of CL/cyt-c interactions. 
Molecular modeling methods, including Gaussian network modeling (GNM), molecular docking, 
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prediction of orientation of cyt-c with respect to the membrane and coarse-grained molecular 
dynamics (CG-MD) simulations were used to complement the NMR studies.  
5.5.2.1 Predicting CL Binding Sites on cyt-c by docking 
Autodock Vina was used to predict putative binding sites by molecular docking studies using the 
structure of native horse heart cyt-c (PDB ID: 1HRC) and TOCL. We grouped the nine top-
ranked CL binding poses into three possible CL binding sites based on binding affinities, 
probability of occurrence and visual inspection of the models (to classify the models based on 
their similarities).  
Table 5-2 Residues interacting with CLs in each model, predicted by molecular docking. 
Probability 
of Binding 
Pocket 
Residues interacting with CL (in 5Å distance to CL) 
Binding 
Energy 
(kcal/mol) 
4/9 
Model1: V3-E4-K7-K8-F10-V11-A15-Q16-H18-T19-V20-E21-K22-G24-
K25-K27-Y97-K100-A101-E104 
-3.3 
Model2: V3-E4-K5-K7-K8-F10-V11-V20-E21-K22-H33-Y97-K100-A101-
E104 
-3.2 
Model7: E4-K7-K8-F10-V11-Q12-A15-Q16-H18-T19-V20-E21-K25-K27-
Y97-K100-A101-E104 
-3.0 
Model8: V3-E4-K7-K8-F10-V11-Q12-K13-A15-Q16-C17-H18-T19-V20-
E21-K27-T28-Y97-K100 
-3.0 
2/9 
Model3: T49-D50-A51-N54-K55-E66-N70-K72-K73-Y74-I75-P76-G77-T78-
K79-M80- I81 
-3.1 
Model6: T49-D50-A51-N54-K55-I57-N70-K72-K73-Y74-I75-P76-G77-T78-
K79-M80-I81 
-3.1 
3/9 
Model4: N31-H33-G34-L35-F36-G37-R38-K39-Q42-A43-P44-T58-W59-
K60-K99-T102-N103-E104 
-3.1 
Model5: E21-K22-G23-G24-K25-H26-N31-L32-H33-G34-F36-G37-R38-
K39-G41-Q42-A43-P44-G45-F46-T47-Y48-K53 
-3.1 
Model9: E21-K22-G23-G24-H26-N31-H33-G34-L35-F36-G37-R38-P44-
G45-T58-W59-K60-E61-E62-K99-T102-N103-E104 
-3.0 
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Representatives of each binding site are shown in Figure 5-7 A-C and the residues within 5Å of 
TOCL are listed under each model shown and for all nine models in Table 5-2.  
The first binding site (Figure 5-7 A), which we will refer to henceforth as the “proximal 
site” includes site L and several other residues in vicinity of proximal heme ligand His18. It 
consists of 6 positively charged Lys, 6 hydrophobic amino acids, 3 negatively charged Glu. 
His18 is also positively charged [151]. The acyl chains of TOCL are aligned toward the N- and 
C-terminal helices H1 and H5, respectively. The Glu residues may facilitate interactions of cyt-c 
with positively charged groups of zwitterionic lipids, such as the choline group of 
phosphatidylcholine, an abundant lipid in any biological membrane. Thus, the nature of the 
amino acids and secondary structures present in the proximal site supports involvement of 
electrostatic (specifically with CL, but potentially also other lipids in which CL is embedded) 
and hydrophobic forces in the cyt-c/CL interactions. A close proximity of Lys25 and Lys27 
nitrogen atoms to oxygens in the CL phosphate groups may result in stabilization of the 
interaction through hydrogen bond formation. A recent survey of amino acids present in known 
CL binding pockets [152] identified the motif G as characteristic of CL binding. This motif is 
also present in the CL proximal site. 
The second CL binding site (Figure 5-7 B), henceforth referred to as the “distal site” 
includes site A and several residues in close proximity of the distal heme ligand, Met80. The 
composition of this site is overall similar to that of the proximal site and also comprises four 
positively charged Lys, 4 hydrophobic and 2 negatively charged amino acids (Asp50 and Glu66). 
In this site, the CL acyl chains are extended around helices H2 and H4. 
The third predicted binding site (Figure 5-7 C) is only composed of random coil. This site 
consists of 5 positively charged (R38 and 4 Lys), 1 negatively charged, and 4 hydrophobic 
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residues. This site is also located on the proximal side of the heme but does not include the 
critical heme-coordinating residue His18. The third binding site does not show overlap with 
previously identified binding sites, but is in proximity to the previously proposed site C (Asn52). 
As for the proximal site, the motif G (K,L) is present. Furthermore, its high abundance of Gly 
and positively charged residues and low abundance of Leu, Val, Ile are all characteristic of CL 
binding [152]. Finally, this binding site contains Y48, which was recently identified as a CL 
binding residue [153]. 
5.5.2.2 Predicted contacts of cyt-c with membrane surfaces 
Clearly, the interaction of cyt-c with a single CL molecule as used in docking studies is an 
oversimplification as CL is embedded in a membrane in vivo. We therefore investigated the 
predicted orientation of cyt-c with respect to membranes using the OPM server [154, 155].  
 
 
Figure 5-8 The orientation of cyt-c with respect to the membrane predicted using OPM server.  
This orientation is highly in concert with the proposed proximal and distal binding sites. 
 
The orientation of cyt-c with respect to the membrane according to OPM is shown in Figure 5-8. 
This orientation highly correlates with the proposed proximal and distal binding sites. The 
residues Lys22, Lys25, Lys27, His33, Arg38, Lys72 and Lys73 are all calculated to be part of 
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the OPM membrane-binding interface on cyt-c. Moreover, several hydrophobic residues around 
and including M80 are predicted to be part of the interface. This suggests the proximal and distal 
sites may be viewed as a joint albeit not contiguous binding site. 
5.5.2.3 Coarse-grained molecular dynamics simulation of cyt-c interaction with 
membranes 
Ideally, we would like to study the interaction of cyt-c with CL further in the context of the lipid 
environment provided by the membrane. However, considering the large system size and long 
simulation time required to study the interactions of proteins with membranes, we chose CGMD 
simulations, rather than full atomistic MD simulations. CG-MD simulations offer advantages due 
to the greater length and time scales possible to capture possible interactions and to study the 
consequences of the interactions on both protein and lipid bilayer. 
 
  103 
Figure 5-9 Cyt-c interacts with higher 
affinity to the membrane containing a 
larger amount of CL.  
A. I. Schematic representation of the 
distance between COM of cyt-c and center-
line of the membrane; II-IV. The distance of 
cyt-c to the membranes containing pure 
DOPC, DOPC-10 mol% CL and DOPC-20 
mol% CL over 1 μs of three independent 
CG-MD simulations, respectively. Dotted 
line represents the membrane surface. B. 
The comparison of the typical final 
configuration of the interactions of cyt-c 
with the membranes containing 10 and 20 
mol% CL. Representation guide: transparent 
cyan: DOPC acyl chains; green: CL acyl 
chains; transparent pink: choline and 
phosphate groups of DOPC; red: head 
groups of CL (two phosphate groups and 
one connected glycerol backbone); 
transparent blue: glycecrol backbone of 
DOPC; blue: glycerol backbone of CL; 
Helices: Blue: residues 3-13, Green: resides 
50-54, Yellow: resides 61-67, Orange: 
resides 71-74 and Red: residues 88-103.  
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Three independent CG-MD simulations of the interactions of cyt-c with membranes of different 
compositions varying in the amount of CL (0, 5, 7.5, 10 and 20 mol% embedded in DOPC) were 
run for 2μs each. The schematic representation in Figure 5-9 A.I. illustrated how distances of the 
center of mass (COM) of cyt-c with respect to the center of the membrane were calculated. In the 
absence of CL, cyt-c did not interact with the membrane (Figure 5-9 A.II.), while addition of 
10% CL resulted in 2 out of 3 simulations in a bound state (Figure 5-9 A.III and IV). The 
membrane containing DOPC-20 mol% TOCL always resulted in a bound state (Figure 5-9 A.VI. 
and B.II.). 
The analysis of cyt-c residues located in 5Å distance of any CL molecules at the final 
configuration of each simulation, confirmed the simultaneous presence of the distal (residues 72-
88) and proximal (residues 5-18 and 22-27) CL binding sites on cyt-c in two of the simulations 
and the third binding site (without the other two) in one of the simulations (Table 5-3).  
In one of the three CGMD simulations, the third binding site from docking was observed. 
When relaxing the elastic network constraints on the protein and thus allowing greater flexibility 
in the protein structure, a 300 ns further simulation resulted in a reorientation of cyt-c into the 
orientation found in the other two simulations, where proximal and distal binding sites are 
occupied together. 
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Table 5-3 Residues interacting with CLs at t=1 μs for each individual CG-MD simulation. 
Simulation ID 
Cyt c Residues Interacting with CLs  
at t=1 μs 
CL 
Concentration  
(mol%) 
CGMD-
ID 
5 
1 -- 
2 -- 
3 K55-N70-P71-K72-K79-M80-K86-K87-K88-R91 
7.5 
1 A51-N54-K55-K73-Y74-P76  
2 K22-G24-K25-H26-K27-H33-L35-Q42-P44-G45-F46-T47-K53 
3 -- 
10 
1 K22-K25-H33-G34-R38-K39-P44-K53-N54 
2 G23-H26-H33-L35-R38-K39-Q42-P44-G45-K53-K100-N103 
3 K55-N70-K72-K73-Y74-I75-G77 
20 
1 
K5-K8-I9-Q12-K13-C14-Q16-C17-T19-K24-K25-K27-T28-G29-F46-
Y48-A51-K55-E69-K72-K73-Y74-I75-P76-K79-G84-K86-K87 
2 
K5-K8-I9-Q12-K13-Q16-C17-K25-H26-K27-F46-Y48-T49-K72- P76-
G77-K79-M80-A83-K86-K87-K88-T89 
3 K25-H26-H33-R38-K39-G41-Q42-A43-P44-G45-F46-T47-K53-N54 
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 Figure 5-10 Interactions of Cyt-c induce CL clustering on the membrane, which leads in a negative curvature 
on the membrane surface.  
Final configurations of the head groups of the lipids in the membrane containing A. 7.5, B. 10 mol% and C. 20 
mol% CL interacting with cyt-c, I. top and side views with cyt-c presentation, II. top and side views without cyt-c 
presentation – to represent CL-clustering underneath of the protein. Representation guide: transparent pink: choline 
and phosphate groups of DOPC; red: head groups of CL (two phosphate groups and one connected glycerol 
backbone); transparent blue: glycecrol backbone of DOPC; blue: glycerol backbone of CL; colorful particle: Cyt c. 
 
Effect of cyt-c interactions on CL-containing membranes –The CG-MD simulations not only 
shed light on the details of the amino acids on cyt-c involved in the interaction with the 
membrane, but also show how cyt-c affects the membrane. In particular, we observed very 
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clearly that the strong interactions of cyt-c with CL-containing membranes lead to CL clustering 
(Figure 5-9 B, and Figure 5-10), in line with previous studies [156, 157]. This clustering in turn 
induces a negative curvature on the membrane surface, especially visible at the highest 
concentration of CL used (Figure 5-10 C.II.). 
 
 
Figure 5-11 Number of cyt-c residue interacting with membrane and number of CL interacting with cyt-c 
enhance by increasing CL concentration in the membrane, indicating higher affinity of cyt-c to interact with 
CL-rich membranes.  
A. Average number of cyt-c resides, including all and positively charged residues, interacting with CL-containing 
membranes at t = 1 μs (n=3). B. Average number of CL interacting with cyt-c at t = 1 μs (n=3). 
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It is well known experimentally that not only in the eukaryotic mitochondrial membrane, but also 
in bacterial membranes, CL localization can induce a negative curvature on the membrane [158]. 
Further analysis of the final configurations of the CG-MD trajectories revealed that the number 
of residues interacting with membrane proportionally increases with increasing CL concentration 
(Figure 5-11 A). Furthermore, the number of CL molecules interacting with cyt-c also increases 
with increasing CL concentration (Figure 5-11 B). The effect is even more pronounced when 
considering the two CGMD simulations that overlap with distal and proximal binding sites and 
the CGMD simulation the overlaps with the third binding site separately (Figure 5-11 B). In the 
latter, the number of CL molecules interacting with cyt-c is significantly smaller (6 versus 14 and 
15) and the membrane is not curved. This finding strongly suggests that the engagement of cyt-
c’s third binding site with the membrane is an unproductive one. 
5.5.2.4 Comparison with Experimental Results 
The modeling data were compared with the solution NMR data of CL binding to cyt-c. The 
experiments were performed either by maintaining the same molar ratio between TOCL and 
DOPC in phosphate buffer at pH 6 or the same total lipid concentration in Hepes buffer at pH 
7.4.  The gradual decrease in signal intensity as a result of TOCL binding at pH 6 predominantly 
affects the distal and proximal sides of the heme, but then also extends to the left and right sides. 
The Hepes pH 7.4 conditions result in an earlier disappearance of all peaks (complete 
disappearance of all peaks at ratio 1:5 in Hepes pH 7.4 as opposed to 1:6 in phosphate pH 6), 
which means that cyt-c is fully attached to the large liposomes which do not tumble sufficiently 
fast on the NMR time scale to allow peak detection.  
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Additionally, the initial rate of substrate oxidation measured by fluorescence spectroscopy in 
Hepes buffer at pH 7.4 and phosphate buffer at pH 6 (in correspondence with the NMR studies). 
The activity measurement in line with NMR and modeling studies confirmed that higher ratios of 
CL/cyt-c lead to strong interactions and consequently higher peroxidase activity.  
5.5.2.5 Discussion and conclusion of interactions of CL and cyt-c 
The initiation and formation of the cyt-c/CL complex, which leads to cyt-c conformational 
changes and peroxidase activity of cyt-c is pivotal for its role in the early stages of apoptosis. 
The nature of binding of CL to cyt-c, including affinity, stoichiometry and location of binding 
sites remains unclear despite numerous studies [125, 131, 132, 140, 143, 159-161]. Emphasis has 
been on the electrostatic interactions between negatively charged phosphate groups on CL and 
positively charged residues on cyt-c and it was proposed that these electrostatic interactions 
initiate the formation of the complex. It was proposed that only subsequent to electrostatic 
attraction, hydrophobic and hydrogen bonding interactions between cyt-c and the acyl chains 
develop and ensure the tight binding of cyt-c to anionic phospholipids [118, 125, 131, 132, 160]. 
It has also been argued that this second stage tight binding is the major cause of partially 
unfolding the protein [162, 163]. A number of experiments exhibit bi-phasic characteristics. It 
was therefore tempting to speculate that a 2-step process comprising electrostatic interaction in 
step 1 followed by hydrophobic interaction in step 2 is responsible [121, 136, 159, 164]. The 
two-step models, however, are not able to explain the observation of multiple binding sites and 
the details of the interactions are controversial. 
To better understand the interplay of different binding sites and multiple modes of 
binding proposed previously, we used molecular modeling —in complement to available NMR 
data— to study the cyt-c/CL interaction and conformational heterogeneity of cyt-c structure. 
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Molecular docking identified three possible locations for the interaction of CL with cyt-c, and 
available NMR spectroscopy data provides evidence that all of these sites are actually engaged. 
How can this be possible given the locations on opposite ends of the protein? The answer lies in 
the fact that the interaction of cyt-c with CL has to be seen in the context of the membrane. Our 
CGMD and OPM say that the two binding sites identified by docking are actually one when 
considering the extended size of the membrane and availability of multiple CL molecules within 
and that cyt-c embeds partially into the membrane.  
The simulation further supports the notion that both, electrostatics and hydrophobic 
forces combined lead to form a tight CL/cyt-c complex and we no longer need to assume a two-
step process as in prior models. The ability to bind cyt-c simultaneously at two opposing ends of 
the heme provides a natural path to formation of the peroxidase by opening the heme crevice 
through “pulling” by the membrane. We thus consider the simultaneous occupation of the distal 
and proximal sites as “productive” binding. We cannot distinguish if membrane curvature 
enhances binding of CL to cyt-c in this manner, or if the strain imposed on the membrane by 
binding is the driving factor for curvature formation. Either way, our results support a model in 
which cyt-c is partially and stably embedded in a locally curved and CL-rich membrane patch. 
We propose that one bound state is the productive binding at proximal and distal sites and 
that the other bound state is the unproductive binding at the third site. The available solution 
NMR results indicate that all binding sites are engaged. Due to the nature of the measurements it 
is not possible to quantify the relative ratio of the two modes of binding at this time. 
The CGMD results are also in good agreement with the NMR and fluorescence results 
respect to the ratio of CL needed to create a peroxidase. Increasing the CL concentration 
enhances the affinity of cyt-c for the membrane. Remarkably, cyt-c recruits CL to form a cluster 
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in the membrane, which demonstrates that multiple CL molecules (not one alone) stabilize the 
cyt-c/CL complex. 
Taking together the conformational studies of cyt-c and interaction studies with CL, we 
propose that gain of peroxidase activity by the cyt-c/CL complex is not a small molecule induced 
effect, but rather is mediated by the interaction with the extensive surface area involved in 
binding the CL containing membrane bilayer. This has important biological implications for 
modulating cyt-c peroxidase activity. The extensive surface area formed between CL and cyt-c is 
reminiscent of protein-protein interaction interfaces and the inherent conformational flexibility of 
cyt-c identified by the NMR relaxation measurements is crucial for enabling this interaction.  
5.5.3 Computational Studies if CL-signaling in mitophagy 
Two types of macroautophagy have been identified so far, nonselective and cargo-specific 
autophagy. Nonselective autophagy occurs on nutrient deficiency to supply cells with essential 
metabolic building blocks to the point that nutrients can be gained again from the extracellular 
environment. Cargo-specific autophagy occurs during nutrient-rich conditions to mediate the 
removal of redundant or injured organelles and protein aggregates, which could be toxic [165]. 
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Figure 5-12 Two different autophagy pathways 
a. non-selective autophagy occurs when cells are deprived of nutrients, and b. cargo-specific autophagy that 
includes mitophagy occurs to eliminate mitochondria, either to regulate their number or to specifically remove 
damaged mitochondria (adapted from [165]). 
 
Mitophagy is a well-studied type of cargo-specific autophagy to remove mitochondria selectively 
(Figure 5-12) [165]. Mitophagy was coined by Lemasters and colleagues [166] to describe the 
engulfment of mitochondria into vesicles that are coated with the autophagosome marker MAPI 
light chain 3 (LC3; a homologue of yeast Atg8). This process can occur within ~5 minutes [165]. 
LC3 (mammalian homologue of yeast Atg8) is an ubiquitin-like protein that is covalently 
attached to phosphatidylethanolamine (PE) during autophagosome biogenesis. LC3 integrates 
into autophagosome, helps the growing isolation membrane and participates in cargo recruitment 
[167]. However, the details of how mitochondrial damage can induce mitophagy remains to be 
Mitophagy in yeast
Mitophagy has been observed in yeast17,18, 
which has facilitated the study of its molec-
ular mechanisms. The product of uth1 is 
a SUN domain-containing protein that is 
located partially in the outer mitochondrial 
membrane (OMM), nd his was found to
be required for eliminating excess mito-
chondria that had been made redundant 
following nutrient changes18. Furthermore, 
ancient ubiquitous protein 1 (Aup1; also 
known as Ptc6), a member of the phos-
phatase 2C (PP2C) superfamily, was shown 
to facilitate mitophagy in stationary phase 
yeast grown under conditions in which res-
piration is favoured, perhaps reflecting the 
quality control elimination of overworked 
mitochondria17.
More recently, two groups independently 
used mitophagy screens to identify dozens 
of new gene products that are required for 
this process, some of unknown function 
and other s with functions that were not 
previously linked to autophagy21,22. In these 
screens, mitophagy was identified by the 
accumulation of mitochondrial proteins in 
the vacuole of stationary-phase respiring 
cells17. Although Aup1 and Uth1 were not 
identified in these studies, perhaps owing 
to the use of different yeast strains, both 
groups found that the autophagy protein 
Atg32 is necessary for mitophagy21,23. Atg32 
(which has no known metazoan homo-
logue) is a 60-kDa protein spanning the 
OMM, with acarboxy-terminal domain in 
the intermembrane space and a ~40-kDa 
amino-terminal region in the cytosol. It 
is required for mitophagy that occurs in 
response to enforced respiration but not 
for non-selective autophagy in response to 
nutrient deprivation or for pexophagy23. 
Under mitophagy-inducing growth con-
ditions, Atg32 binds to Atg11, which is 
known to recruit a range of cargo, including 
peroxi somes, into autophagosomes by inter-
acting with Atg8. Inter stingly, the c tosolic 
domain of Atg32 contains a WXXL-like 
Atg8-binding motif, which is required for 
binding to Atg8 and for mitophagy. Thus, 
Atg32 can interact with Atg8 indirectly 
through Atg11 and directly through the 
WXXL-like motif (FIG. 2a). The direct and 
indirect (when bridged by Atg11) associa-
tion of mitochondrial membrane-anchored 
Atg32 with isolation membrane-bound 
Atg8 is thought to recruit mitochondria into 
autophagosomes. Although Atg32 expres-
sion increases under oxidizing conditions, 
which suggests that it might also partici-
pate in mitochondrial quality control21, no 
defects in mitochondria were identified in 
Atg32-null yeast. How the expression and 
activity of Atg32 are regulated to eliminate 
the appropriate number of mitochondria 
remains unknown and is an intriguing area 
for further study. The range of genes that 
have been identified as being necessary for 
mitophagy in yeast suggests that distinct 
pathways probably mediate mitophagy for 
different purposes.
Mitophagy in red blood cells
Removal of undamaged mitochondria also 
occurs during key developmental processes. 
In most mammals, mature red blood cells 
lack mitochondria, and this is achieved 
by mitophagy during the maturation of 
immature red blood cells, which are known 
as reticulocytes20,24,25. The OMM protein 
NIP3-like protein X (NIX; also known as 
BNIP3L) could be involved in this process, 
as its expression greatly increases during 
the terminal differentiation stages of red 
blood cells26, and mature red blood cells 
from mice lacking NIX retain residual 
mitochondria19,27. NIX (which has no yeast 
homologue) was originally thought to be 
a BCL-2 homology domain 3 (BH3)-only 
protein involved in apoptosis, so it could 
potentially induce mitophagy through 
apoptotic signalling. However, phylogenetic 
studies indicated that NIX is not a BH3-only 
protein28, and NIX-mediated mitophagy in 
reticulocytes does not seem to involve  
apoptotic mechanisms as it does not require 
the pro-apoptotic B cell lymphoma 2 
(BCL-2) family proteins BAX or BCL-2 
antagonist/killer (BAK)19.
NIX is localized to the OMM and contains 
a WXXL-like motif facing the cytosol, which 
binds the mammalian Atg8 orthologue, LC3, 
and the LC3 homologue, GABA receptor-
associated protein (GABARAP), in vitro and 
in vivo29,30. This motif may directly recruit 
isolation membranes to mitochondria. The 
induction of mitophagy by NIX is thought 
 be mediated, at least in part, by direct 
binding to LC3 and GABARAP through 
its WXXL-like motif (FIG. 2b). Consistent 
with this theory, mitophagy is not fully 
restored in NIX-null reticulocytes that are 
rescued with NIX lacking the WXXL-like 
motif. Although mitophagy can be rescued 
in NIX-deficient reticulocytes by depolar-
izing mitochondria with carbonylcyanide 
p-trifluoromethoxyphenylhydrazone (FCCP) 
or the apoptosis-inducing BH3-mimetic 
Figure 1 | Non-selective autophagy and mitophagy have different roles. a | Non-selective autophagy 
occurs when cells are deprived of nutrients. It degrades a range of cytosolic contents, including proteins 
and many types of organelles. After their recruitment into isolation membranes, cytosolic components 
are s aled into autophagosomes that fuse with lysosomes. The degradation of these c m onents in the 
lysosome supplies building blocks for re-use and for metabolism to provide ATP. b | By contrast, 
mitophagy occurs to eliminate mitochondria, either to regulate their number or to specifically remove 
ones that are damaged. Mitochondria are selectively recruited into isolation membranes, which seal 
and then fuse with lysosomes to eliminate the trapped mitochondria.
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elucidated. Mitophagy is a quality control stage for the damaged mitochondrial material for 
selective removal. Moreover, mitophagy is required for steady-state turnover of mitochondria to 
adjust mitochondrion numbers, according to cell demands [168]. 
 
 
Figure 5-13 The mechanisms of mitophagy.  
a. In yeast this occurs through OMM protein autophagy-related 32 (Atg32). b. Red blood cells, during 
differentiation, lose their mitochondria through mitophagy. NIX has a WXXL-like motif, which binds to LC3 and 
sequestration of mitochondria into autophagosomes. c. For the damaged mitochondrion, the kinase PTEN-induced 
putative kinase protein 1 (PINK1) accumulates, and recruits the E3 ubiquitin ligase parkin from the cytosol. Parkin 
ubiquitylates mitochondrial proteins to induce mitophagy. This may mediate mitochondrial quality control (adapted 
from [165]). 
 
ABT737 (REF. 27), such depolarization seems 
to activate a NIX-independent mitophagy 
pathway25. The core autophagic pro-
teins, UNC51-like kinase 1 (ULK1) and 
ATG7 are also required for mitophagy in 
reticulocytes20,24,25.
Mitophagy in disease
Recent work has linked defects in mitophagy 
to Parkinson’s disease. Two genes, which 
encode the OMM kinase PINK1 (REF. 31) and 
the cytosolic E3 ubiquitin ligase parkin32, are 
mutated in autosomal recessive Parkinson’s 
disease. These proteins have been found 
to work in the same pathway to suppress 
mitochondrial damage in flies33–35, which can 
lead to loss of flight muscle and dopamin-
ergic neurons, and to male sterility that is 
ameliorated by promotion of mitochondrial 
fission36–38. Below we describe the signalling 
pathway mediated by PINK1 and parkin that 
induces mitophagy in mammalian cells.
Parkin translocates to damaged mitochondria. 
Parkin is an E3 ubiquitin ligase, dysregula-
tion of which is linked to Parkinson’s disease 
and loss of neurons of the substantia nigra. 
Parkin is robustly expressed in many tis-
sues, including brain, skeletal muscle, heart 
and liver tissues, which suggests that it 
has a widespread physiological role39. One 
hour after stress induction by mitochon-
drial uncouplers (which mimic damage 
by decreasing the mitochondrial inner 
membrane electrochemical gradient that is 
used to produce ATP), parkin translocates 
from the cytosol to mitochondria in many 
cultured cell types, including neurons and 
HeLa cells40 (Supplementary information S1 
(movie)). Administration of other mito-
chondrial poisons, such as Paraquat in many 
cell types40 and azide in cells lacking mito-
chondrial DNA (mtDNA)39, also induces 
parkin translocation to mitochondri a. 
Interestingly, when mitochondrial fusion is 
blocked and a subset of mitochondria become 
impaired and lose membrane potential, 
parkin translocates to the subset of dam-
aged mitochondria without accumulating 
on healthy mitochondria in the same cell40. 
Furthermore, when cells are incubated for 
up to 1 day with mitochondrial uncouplers, 
parkin mediates selective elimination through 
mitophagy of all mitochondria in a large pro-
portion of the cells40. Based on the selective 
recruitment of parkin to damaged mitochon-
dria and the induction of their removal by 
mitophagy, it was proposed that parkin medi-
ates a mitochondrial quality control pathway 
to maintain organelle population fidelity by 
removing damaged mitochondria. Consistent 
with this proposal, overexpression of parkin 
in heteroplasmic cybrid osteo sarcoma cells 
eliminates mitochondria that have deleterious 
mutations in cytochrome oxidase subunit I 
(COXI; encoded by mtDNA) and not wild-
type mitochondria. This selectively elimi-
nates the mitochondria with mutations in 
COXI, thereby enriching cells with wild-type 
mtDNA and rescuing cytochrome oxidase 
activity39.
Parkin is recruited by PINK1. The trans-
location of parkin to uncoupled mitochon-
dria and the induction of parkin-mediated 
mitophagy require the activity of PINK1 
(REFS 41–44). Indeed, ectopic expression 
of PINK1 (REFS 45,46) or experimentally 
induced accumulation of PINK1 on mito-
chondria41 are sufficient to induce parkin 
translocation and mitophagy in the absence 
of mitochondrial uncoupling. Genetic stud-
ies in flies also show that PINK1 and parkin 
function in the same pathway to prevent 
pathology in vivo34,35,47, which is consistent 
with the hypothesis that mitophagy induc-
tion may be a key physiological function 
of PINK1 and parkin. Interestingly, NIX 
has been recently reported to promote 
parkin translocation and parkin-mediated 
mitophagy in mouse embryonic fibroblasts48.
Figure 2 | The Atg32, NIX and PINK1–parkin pathways of mitophagy. Mitophagy requires the 
specific labelling of mitochondria and their recruitment into isolation membranes. a | In yeast this 
occurs through the outer mitochondrial membrane protein autophagy-related 32 (Atg32), which can 
bind the isolation membrane protein Atg8 through its WXXL-like motif. How mitochondria are speci-
fied for removal to calibrate the mitochondrial population density according to the cell’s metabolic 
demand remains unknown but may occur through the adaptor protein Atg11, which binds both Atg32 
and Atg8 and c uld physically link mitochondri  and isolation membranes. Finally, the isolation mem-
branes seal mitochondria in autophagosomes and fuse with lysosomes to allow degradation. b | During 
differentiation, red blood cells lose their mitochondria through mitophagy. Expression of the outer 
mitochondrial membrane protein NIP3-like protein X (NIX; also known as BNIP3L) increases during red 
blood cell differentiation and is required for mitochondrial removal. NIX has a WXXL-like motif, which 
binds to MAP1 light chain 3 (LC3; a homologue of yeast Atg8) on isolation membranes and is thought 
to mediate the binding and sequestration of mitochondria into autophagosomes. c | When mitochon-
dria are damaged and lose membrane potential, the kinase PTEN-induced putative kinase protein 1 
(PINK1) accumulates (shown as a halo around the mitochondrion) and recruits the E3 ubiquitin ligase 
parkin from the cytosol specifically to the damaged mitochondrion. Parkin ubiquitylates mitochondrial 
proteins and causes mitochondria to become engulfed by isolation membranes that then fuse with 
lysosomes. This may mediate mitochondrial quality control.
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Three mechanisms had been proposed for mitophagy (Figure 5-13) until Chu and co-workers 
describe a novel mechanism for autophagy [165]. They suggested that the binding of the 
externalized CLs —on the surface of a damaged mitochondrion— with LC3 act as an ‘‘eat-me’’ 
signal for mitophagy. With regard to specificity of CL involvement in the signaling process, two 
points should be noted: (i) enrichment of the OMM with CLs is associated with the random 
trans-membrane translocation of different CL species, and (ii) externalized CLs do not contain 
increased amounts of oxidized CL species [28].  
 
Here, we employed computational methods to explore the mechanism of interactions of LC3/CL. 
The modeling data were leveraged to study CL-binding sites of LC3 to propose the key 
residues/domain involve in CL interactions. Moreover, the effect of LC3 interactions on CL-
containing membrane was identified. Our modeling data have been validated using experimental 
data and full atomistic simulations.  
5.5.3.1 LC3 structure and its conserved residues  
Although mechanisms of selective autophagy are just beginning to emerge [169, 170], LC3 
serves as a receptor for cargo adapters that bind protein aggregates [171], and its homolog Atg8 
functions in an analogous role in yeast [172]. Examination of the crystal structure of LC3 reveals 
basic patches at its surface that are not present in the related proteins GABARAP and GATE16 
(Figure 5-14) [173].  
A total of 10 sequences corresponding to the LC3 family corresponding to isoforms (A, B 
and C) were downloaded from SwissProt using the criteria “((gene:MAP1LC3A OR 
gene:MAP1LC3B OR gene:MAP1LC3C))”.  
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Figure 5-14 LC3 structure.  
A. Rat LC3-B structure based on PDB ID: 1UGM. B. Positively (blue) and negatively (red) charged residues of LC3 
—spheres represent the Cα atom of each amino acid. 
The sequence alignment and phylogram of those 10 sequences using ClustalW illustrated in 
Figure 5-15. 
 
Figure 5-15 A. The sequence alignment and B. phylogram of 10 LC3 homologues using ClustalW. 
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5.5.3.2 Predicting CL-binding site on LC3 using molecular modeling 
Molecular docking analysis predicts two CL-binding pockets at the rat LC3-B surface 
(Figure 5-16 A).  
 
 
Figure 5-16 CL-binding site of LC3. 
A. Molecular model of interaction sites for CL binding to LC3 by docking analysis, left is the top-ranked and right is 
the alternative binding site. Representation guide: CL acyl chains are colored cyan, and phosphate groups in orange. 
Surface and cartoon representation of LC3 are merged. B. Thirty-nine LC3 family sequences including isoforms A-
C were aligned with ClustalW and displayed using WebLogo, with symbol heights corresponding to relative amino 
acid frequency. Asterisks denote residues that contact CL in the favored (magenta) and alternate conformations 
(cyan). 
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On both binding sites, there are positively charged residues interacting with the sterically-
constrained head group of CL to stabilized electrostatic interactions. The predicted coordinating 
amino acids, which displayed using WebLogo (Figure 5-16 B), include N-terminal alpha-helical 
residues of LC3, which are highly conserved (Figure 5-15). According to molecular docking data 
we hypothesized that, the electrostatic interactions of CLs phosphate groups with a cluster of 
critical arginine residues of LC3 define the recognition process [21], which has been tested using 
experimental data. Two types of experiments validated that N-terminal residues of LC3 is highly 
involved in CL interactions, i. deleting N-terminus of LC3 and ii. double mutating LC3 at R10 
and R11 prevented the injury-induced increase in co-localization with mitochondria. 
5.5.3.3 Interactions of LC3 with CL-containing membrane  
To supplement the molecular docking predictions of CL-binding pockets at the LC3 surface, 
facilitating identification of key residues for mutagenesis, we used molecular dynamics to 
simulate the binding of human LC3B to PC bilayer membranes containing CL or PA. Three 
independent CGMD simulations of 1 μs each were performed, using different initial velocities 
during equilibration to generate different LC3 orientation versus membrane. In all three runs, 
LC3, originally placed ~20 Å away from the bilayer surface, reoriented and translocated towards 
the bilayer surface to rapidly interact with CL —four snapshots of CGMD1 demonstrated in 
Figure 5-17 as a typical interactions trajectory. The significant displacement of LC3 was driven 
by strong electrostatic interactions between the negatively charged CL head groups and 
positively charged residues on LC3. The overall comparison of the interactions of LC3 with the 
lipid bilayer in the presence or absence of CL suggests that the presence of CL facilitates more 
rapid diffusion towards bilayers followed by stronger interactions.  
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Figure 5-17 Interactions of CL-containing membrane and LC3. CGMD simulations suggest that LC3 triggers 
lateral diffusion of CL and its clustering in the membrane.  
The curvature formation caused by protein binding emphasizes the strong interactions. Initial configuration (t = 0 
ns) LC3 was placed ~2 nm away from the membrane; Final configuration  (t = 1000 ns) LC3 is interacting with CL-
containing membrane. Color guide: head groups of CL, dark blue sticks; acyl chain of CL, light blue sticks; LC3, 
cyan (transparent); N-terminus of LC3 (K5, R10-R11), blue spheres; K49, R68-R69-R70, green spheres; Glu117, 
red sphere. Black arrow shows Glu117 —representing C-terminus of LC3, which stays exposed to the water to play 
the cross-linker role. 
 
The three CGMD simulations indicated the involvement of residues K5, R10 and R11 in the 
initial interactions with the CL-containing bilayer, with recruitment of residues R68-R70 and 
K49 (Table 5-4). 
Although the simulations are likely to provide insights into early recognition events 
rather than thermodynamically stable binding conformations, CGMD simulations implicated 
residues in two regions - K5, R10-R11 and R68-R70 – in early interactions of LC3 with CL 
containing membranes. Notably, the C-terminal region of LC3, which becomes cross-linked to 
autophagosome membranes, remained exposed throughout the simulation (Figure 5-17 the right 
panel), compatible with its proposed bridging role. 
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Table 5-4 Residues of LC3 in contact with CL during CGMD simulation.  
The first contact involves N-terminal residues F7-K8-Q9-R10-R11 [Note overlap with the favored docked 
conformation of F7-R10-R11]. These residues stay in contact throughout the rest of the simulation. While additional 
electrostatic interactions form subsequently, a hydrophobic contribution develops through involvement of V33-I34-
V46-F52-L53-I67 at 100ns, which is further expanded with the addition of V17-V20- L22-I31-I35-Y38-L47-V54-
I64-I66-L71-F79-F80-L82-L83-I95-F108-Y110 at 150ns. A distance of < 5Å was used to identify interacting 
molecules Bold: residues that contact the bilayer after 50ns. Underlined: residues in contact after 100ns. 
Time (ns) Residues 
Number of 
Residues 
40 --  0 
50 F7-K8-Q9-R10-R11  5 
100 
K5-F7-Q9-R10-R11-E14-H27-T29-K30-P32-V33-I34-R37-P45-V46-
K49-T50-F52-L53-I67-R68  
21 
150 
F7-Q9-R10-R11-V17-V20-R21-L22-H27-T29-K30-I31-V33-I34-I35-
Y38-K42-L47-K49-T50-F52-L53-V54-N59-I64-I66-R68-L71-F79-F80-
L82-L83-I95-F108-Y110 
35 
 
Effect of LC3 interactions on CL-containing membrane: The strength of the interactions 
between LC3 and CL in a bilayer membrane is emphasized by the observed CL clustering and 
membrane deformation due to the binding (Figure 5-17 at time equal to 500 and 1000 ns).  
 
CL and lysoCL vs. PA: CGMD simulations of CL- and PA-containing membranes (data are not 
shown) suggest that LC3 fluctuates near PA-containing bilayer surfaces, without significant 
movement toward the membrane. In contrast, the interaction of LC3 with the CL-containing 
bilayer appeared to be stabilized by recruitment of additional interaction sites, particularly for CL 
bearing four acyl chains. LC3 interacts with lower affinity with the membrane containing lyso-
CL (CL with three acyl chains).  
Experimental proof: The data were generated using a gel retardation assay demonstrated that 
recombinant LC3 can directly bind CL liposomes, but not PC liposomes. We also found that 
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LC3 interacts more favorably with CL containing four acyl chains, than with lysoCLs. 
Experimental data also indicates that LC3 shows a stronger affinity for CL than for phosphatidic 
acid (PA) and phosphatidylglycerol (PG). 
 
Interactions of CL and Beclin 1: CL has been reported to bind several proteins, including the C-
terminal domain of the autophagy protein Beclin 1 [174] and the voltage dependent anion 
channel, which is implicated in the FCCP-PINK1-Parkin pathway of mitophagy [175, 176]. 
Consistent with observations that full length Beclin 1 does not interact with membranes [174], 
simulations of the interaction of Beclin 1 with a lipid bilayer containing CL provided little 
evidence for binding (not shown). Thus, it is unlikely that this interaction contributes 
significantly to mitochondrial targeting to the autophagosome in these contexts. 
5.5.3.4 Comparison with Experimental Results 
The modeling data were compared with the double point mutation of LC3, in which either Arg 
10 and Arg 11 or Gln 26 and His 27 were mutated. The Arg 10 and Arg 11 mutation fully 
recapitulated the effects of deleting the α-helices, preventing the injury-induced increase in co-
localization with mitochondria (in line with docking and CGMD simulations) [28]. Additionally, 
full atomistic MD simulations revealed that the positively charged residues in N-terminal domain 
of LC3 are actively involved in the interactions with the CL-containing membrane [28]. 
5.5.3.5 Discussion and conclusions of interactions of CL and LC3 
1A/1B-light chain 3 protein mediates both autophagosome formation and cargo recognition 
during mitophagy. However, the mechanism of recognition of injured/damaged mitochondria is 
not known. Since it has been known that CLs are externalized in damaged mitochondria we have 
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hypothesized that LC3 may recognize these CLs. To test our hypothesis we employed 
computational approaches (in complement with the available experimental data generated in our 
group) to predict CL binding site of LC3. Molecular docking analysis predicts CL-binding 
pockets at the LC3 surface, where Arg and Lys interact with the negative head groups of CL with 
two possible conformations. The predicted coordinating amino acids include N-terminal residues 
of LC3 such as Arg 10 and Arg 11 for the top-ranked conformation or Gln 26 and His 27 for the 
alternative conformation. CGMD simulations of 1,000 ns implicate Arg 10 and Arg 11 in the 
initial interactions of LC3 with CL-containing membranes. Then, it was experimentally validated 
that the truncation of the predicted CL binding domain or even mutation of the predicted key CL-
binding residues impaired mitophagy process. 
Molecular modeling and simulations also predicted that clustering of CL around LC3 may 
serve to stabilize initial electrostatic interactions, with embedding of parts of the protein into the 
bilayer through hydrophobic interactions. If this is correct, such a clustering mechanism could 
help ensure that normal transient fluctuations due to lipid transport dynamics do not trigger 
mitophagy until a critical threshold of LC3–CL interaction density is achieved. It is possible that 
in some systems, the threshold may be modulated by concurrent engagement of other cargo-
targeting mechanisms. 
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6.0 CHAPTER 6: FUTURE DIRECTIONS 
6.1 LIPID SIGNALING DUE TO OXYGENATION OF LIPIDS 
6.1.1 Role of Oxygenated-Lipid-Containing Lipid Droplets in Cancer 
6.1.1.1 Structural role of ox-lipids in LD  
Due to limitation of computational resources and simulations time, we used a relatively small LD 
size compared to the actual LD dimensions in our studies. Thus, our model depicts a higher 
curvature and a higher surface pressure at the interface. To mitigate the size issue, a tri-layer 
model composed of two layers of phospholipids and a central layer of TAGs/oxTAGs can be 
employed in future studies. This model mimics a very large lipid droplet by ignoring the 
curvature. A comparison of both models, small LD and tri-layer system, will provide more 
accurate insight regarding the dynamics behavior of TAGs and oxTAGs. We documented the 
small fraction of TAGs molecules also can be redistributed into the PL monolayer, however, they 
are not stable there. On the other hand, oxTAG reside in PL monolayer, comparing the core, for 
a longer simulations time. We hypothesized that this behavior can be limited in oxTAG in tri-
layer system due to elimination of the curvature effect and the surface pressure at the interface. 
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6.1.1.2 Role of Oxygenated-Lipid-Containing Lipid Droplets in Antigen-Cross 
Presentation 
Our computer modeling data represented that a beta-hairpin motif in the N-terminal ATPase 
domain of HSP70 is actively involved in the interactions with oxygenated lipid species. In future 
studies, the computational and experimental approaches can be utilized to study the effect of 
point mutation(s) of the residues present in this motif, particularly Lys294. Mutation study can 
be performed using both molecular docking and CGMD.  
To gain further insight regarding to chemical bond formation between HSP70 and ox-
lipids, the free energy calculations based on potential mean forces (PMF) can be applied. PMF 
can be calculated for two systems, i. HSP70 anchored on the surface of LD without covalent 
bond formation (current model), ii. HSP70 anchored on the LD surface while initially a chemical 
bond is considered between Lys294 and an aldehyde group of a truncated TAG. Using pulling 
method and umbrella sampling PMF can be calculated and compared for both cases. We 
hypothesize that the covalent binding of Lys249 and one ox-TAG possibly introduces large 
barrier energy to pull HSP70 away from the surface of the LD indicating irreversibility of the 
interactions. 
6.1.2 Mechanism of Phospholipids Peroxidation in Ferroptosis 
The in vivo and in vitro experiments clearly indicated that arachidonoyl- and adrenoyl-PE are 
dominant biomarkers of ferroptosis cell death. However, our molecular docking data represented 
insignificant differences in the binding affinities for five classes of PL (from six). On the other 
hand CGMD simulations suggested two lipids species, including SAPE and SAPI lipids, are 
potentially can interact with the active site of 15LOX. In future studies, we can employ a 
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membrane model to investigate the specificity of 15LOX enzyme to these two lipid species. The 
model membrane should contain PC as a substrate and equal concentration of PE and PI lipids. 
Therefore, the role of these two lipids in the membrane binding behavior can be investigated. As 
we showed, 15LOX deeply penetrates in the membrane, which probably make the catalytic site 
of the enzyme accessible for the lipids embedded in the membrane (in a long enough run). 
Hence, we may be able to observe the interactions of either of these two types of lipids with the 
catalytic site. 
6.2 CL- SIGNALING DUE TO COLLAPSE OF ASYMMETRY 
6.2.1 Interactions of CL and Proteins 
Recently, we describe the collection of the first systematic and, to the best of our knowledge, the 
comprehensive gold standard data set of all known CL-binding proteins. In future works, the 
availability of a gold standard data set can be used in combination with suitable features to 
develop a general classification model that can be applied at the system-wide level to predict if a 
given protein may interact with CL or not.  
Although we have observed clear trends in binding patch properties in CL-binding 
proteins, in future, we can investigate the “specificity”. For example, other anionic phospholipids 
or even other doubly negatively charged small molecules such as GDP or ADP may show similar 
general structural and dynamics features in their respective binding pockets. Moreover, we can 
explore specificity among many CL species —using molecular modeling to predict the binding 
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affinities and binding sites. We hypothesize that TLCL shows higher affinity compared to CL 
with higher degrees of saturations or shorter chains (<18 carbons). 
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